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ABSTRACT 
Current method to treat large soft tissue defects relies on transfer of autologous 
adipocutaneous tissue, a method that is often limited by donor site availability.  
Engineered adipose tissue can potentially serve as a readily accessible substitute to 
autologous tissue.  As immediate vascularization is critical for tissue survival after 
transplantation, it is important for the engineered tissue to contain preformed vasculature 
that can be connected to native circulation via suture anastomosis.  In this thesis I present 
methods to engineer 1) an endothelialized dense collagen tube that can serve as the bridge 
between the engineered tissue and the host circulation and 2) a small-scale, perfusable, 
vascularized adipose tissue.   
This work shows that the endothelialized dense collagen tubes possess sufficient 
mechanical strength and can be implanted in the rat femoral circulation as interpositional 
grafts via suture anastomosis.  It also shows that the crosslinking and culture condition 
has significant effect on the endothelial stability, which in turn affects the patency upon 
implantation.  Implanted tubes can remain patent and conduct blood flow for up to seven 
days.   
 
 vi 
The small-scale adipose tissue contains a preformed vessel that allows immediate 
perfusion and delivery of nutrient to the adipocytes. The vessel possesses good barrier 
function and the adipocytes are both viable and can respond to perfusion of lipoactive 
hormones, insulin and epinephrine, in a physiologically correct manner. In addition, I 
have developed a mathematical model that correlates the growth of adipocytes to the 
distance from the feeding vessel.  
These two constructs can potentially serve as the base unit for engineering larger, 
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Soft-tissue Loss and Current Treatments 
Treatment of large soft-tissue loss that often accompanies high degree burn, 
traumatic injury, tumor resection, and diabetic foot remains challenging.  Currently there 
are two major approaches to treat soft-tissue loss with autologous tissue: lipoinjection and 
transfer of autologous adipocutaneous flap.  In lipoinjection, also called Coleman’s 
technique, adipose tissue fragments is obtained by lipoaspiration and adipocytes are 
separated from free lipid and stromal vascular fraction by centrifugation.  Separated 
adipocytes are then injected into the wound sites.
2-3
  As the native vasculature is 
destroyed during this process, and it usually takes up to five days for vessels to invade 
from surrounding tissue
4
, the injected adipose tissue often loses 20-90% of the volume 
over several months due to lack of vasculature
5, 6
.  Yoshimura and co-workers improved 
the Coleman’s technique by mixing the separated adipocytes with the stromal vascular 
fraction
7
, which contains endothelial cells and adipose derived stem cells and are thought 
to facilitate vascularization.  While this technique partially improved the survival of 
transferred fat, it still lacks sufficient nutrient supply, especially for larger transplants.  
An adipocutaneous flap contains epidermis, dermis, and subcutaneous fat layers with the 
native vasculatures preserved.  During the transplantation, the vessels in the 
adipocutaneous flap are connected to the circulation in the wound site, establishing 
immediate perfusion in the flap which leads to better flap survival.  This approach is 
currently considered as the gold standard for treating large soft tissue loss.  However, as 
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the fat flap is taken from a donor site, this technique is limited by donor site availability 
and may result in donor-site morbidity
8, 9
.  For patients with large soft-tissue loss, a 
volume-stable adipose tissue substitute remains elusive.  Engineering of a stable and 
functional vascularized adipose tissue that can be grafted as a perfused unit could be 
invaluable for treating soft-tissue loss. 
 
Vascularizing Engineered Tissues 
It is agreed that immediate perfusion and delivery of nutrient is required for the 
survival of implanted tissue
10, 11
.  And it follows that engineered adipose tissue need to 
contain vasculature that enables perfusion.  Currently there are two approaches to 
vascularize an engineered tissue.  In the first approach, endothelial cells are incorporated 
in a scaffold of extracellular matrix protein such as collagen
12
 or other biocompatible 
materials such as polylactic acid
13
.  Given the right growth factors, embedded endothelial 
cells will self-organize in to capillary-like vessels.  As capillaries formed this way are too 
small to be cannulated, it is impossible to establish immediate perfusion.  Instead, 
perfusion is established by inosculation of engineered capillaries with host vessel, and 
this process usually takes several days
12
.  In the second approach, empty channels are 
first created in the scaffold either by stacking two or more pieces micropatterned gels 
together
14





, and subsequently removing the mold.  The empty channels are then 
seeded with endothelial cells which proliferated to form a monolayer.  Vessels formed 
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using this approach have pre-determined structure and are usually around hundred-
micrometer scale, which makes it possible to perfuse. 
The majority of the studies on engineered vascularized adipose tissue employed the 
first approach, where adipose-derived stem cells are added to the endothelial cell-scaffold 
mixture
17-21
.  While tissues formed this way have structure closer resembles that of in 
vivo adipose tissues, and may be an excellent platform to study adipocyte-vascular 
interactions, the fact that it may take several days to establish perfusion makes it 
unsuitable to treat larger soft tissue defect.  In this work I formed vascularized adipose 
tissue using the second approach by preforming perfusable, endothelial lined channels. 
 
Connecting Engineered Tissue to Host Circulation 
In addition to a perfusable vasculature, connection to the host circulation in the 
wound site is required to establish immediate perfusion.  The engineered adipose tissue is 
usually very soft and cannot withstand surgical anastomosis; therefore, a vascular pedicle 
of sufficient mechanical strength is required to serve as the bridge between the 
engineered tissue and host vessels.  As traumatic injuries often occur at the extremities 
where the host vessels are on the order of 1 mm in diameter, engineered vascular pedicles 
should also match this size.  
While engineered vessels of 3-6 diameter have been extensively studied 
22, 23
, there 
are only a handful studies on engineered vessels of ≤ 1 mm outer diameter for 
microsurgical applications.  Nakayama and co-workers produced “Microbiotubes” by 
utilizing body’s natural encapsulation process
24
, Narita’s group and Yim’s group both 
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employed electrospun polymer.  While the engineered vessels produced by these groups 
showed promising outcome when implanted as standalone grafts, it is unclear how to 
incorporate these vessels into collagen-based, engineered adipose tissue.  The current 
work looked at engineering 1-mm diameter vessels by endothelializing condensed 
collagen tubes. 
 
Design Criteria and Chapter Outline 
In order for the engineered adipose tissue to survive and retain its volume after 
implantation, we identified three important design criteria.  First, the adipose tissue must 
contain vasculature that allows immediate perfusion after implantation.  Second, the 
engineered adipose tissue should possess mechanical and physiological properties 
comparable to those of native adipose tissues.  Third, the engineered adipose tissue 
should be of sufficient volume to be clinically relevant.   
In Chapter Two, I presented a method to form dense collagen tubes and showed 
that they possess sufficient mechanical strength to withstand surgical anastomosis and 
arterial flow.  In Chapter Three, I evaluated the in vivo response to endothelialized dense 
collagen tubes that are implanted in the rat femoral circulation as interpositional grafts.  I 
also explored means to increase the endothelial stability, which in turn helps improve the 
patency rate after implantation.  In Chapter Four, I presented a method to engineer a 
small scale vascularized adipose tissue that can be immediately perfused.  As in human, 
expansion and reduction of fat depots happens throughout life, I also showed that 
adipocytes in the engineered tissue responds to lipogenic and lipolytic hormones.  
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Furthermore, I developed a mathematical model that correlates the growth of adipocytes 
to the distance from the feeding vessel.  I believe this will help in designing the optimal 
vascular geometry when building larger scale adipose tissue.  These two constructs 
provide the building blocks for engineering, implantable adipose tissue for treating soft 
tissue injury. 
The appendix presents a computational algorithm that determines the vascular 
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Tissue-engineered vascular grafts (TEVGs) have been studied for decades as an 
alternative to autologous artery and vein grafts
25
.  Compared to autologous grafts, TEVGs 
are more readily available and more flexible in dimensions.  As TEVGs can have a 
functional endothelial lumen, they are less likely to cause the acute thrombosis and 
chronic inflammation that are commonly associated with synthetic polymer grafts
25
.  
Much has been done to fabricate “small-diameter” grafts 3 to 6 mm in outer diameter that 
provide the strength and compliance of a native vessel
22, 26, 27
, with some designs already 
in clinical trials
23, 28
.  In comparison, little is known about making grafts with 1-mm-scale 
outer diameter.  Such “very small-diameter” vessels are often employed for microsurgical 
peripheral revascularization, such as in the replantation of amputated fingers.  In recent 
years, roughly 15% of the patients who had upper extremity amputation underwent 
replantation surgery
29
.  In avulsion injuries, the wound surface is often mangled, leaving 
short artery stubs insufficient for arterial anastomosis.  In principle, a vascular graft of 
diameter   ≤ 1 mm could be used in place of a traditional venous bypass to bridge 
between the proximal and distal artery stubs. 
Because they are designed for different implantation environments, grafts in the 3-6 
mm diameter range and those of ~1 mm diameter require different design criteria.  Most 
prominently, compliance matching between the arterial wall and graft is absolutely 
crucial in ensuring long-term patency in the larger grafts made for coronary bypass
30
, but 
is less relevant at the microsurgical scale where collaterals will promptly develop and 
only short-term patency is absolutely required
32-33
.  The requirement for anastomotic 
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strength and burst pressure will likely differ for the two diameter scales as well. 
Type I collagen is a common material for making tissue constructs because it has 
superior biocompatibility and promotes cell adhesion.  Weinberg and Bell made the first 
tissue-engineered vascular graft by seeding endothelial cells on the lumen of a collagen 
gel tube
34
.  Notably, the construct was too fragile and had to be supported by synthetic 
sleeves.  Attempts by other groups to increase the strength of tissue-engineered vascular 





, and stiffening collagen using glycation
38
.  Although these 
attempts led to increased graft strength, the gels typically still required a supporting 
synthetic sleeve to obtain surgically acceptable mechanical strength. 
Recently, Nazhat and colleagues produced dense collagen tube constructs with an 
inner diameter of 3.4 mm by compressing native collagen gel into a sheet, which was 
subsequently rolled around a mandrel
39
.  These dense collagen tubes displayed 
circumferential tensile strength and suture knot retention strength similar to that of human 
saphenous vein and human mammary artery.  Similarly, Chaikof and co-workers showed 
that dried collagen-elastin tubes could achieve ultimate tensile strength and Young’s 
modulus comparable to that of a native blood vessel
40
.  Although these tubular constructs 
lacked a complete endothelial lumen, their high mechanical strength suggested that high 
matrix densities may be required to form vascular grafts without supporting sleeves. 
In the current study, we produced dense collagen tubes by drying native rat tail type 
I collagen around a mandrel 0.5-1 mm in diameter.  After the dried collagen tube was 
further crosslinked with 20 mM genipin, it yielded anastomotic strength comparable to 
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rat femoral artery and could withstand the pressure of arterial flow.  Moreover, we 
showed that human umbilical vein endothelial cells (HUVECs) grew into a confluent 
lumen that remained patent for seven days inside these tubes.  Finally, we implanted 
dried-and-crosslinked tubes in the rat femoral circulation, and found that they were 
mechanically stable and sustained blood flow.  To our knowledge, this work provides the 
first successful demonstration of end-to-end suture anastomosis of artery and collagen 
tubes at the 1-mm scale in vitro and in vivo. 
 
Materials and Methods 
Cell culture 
Human umbilical vein endothelial cells (BioWhittaker) were grown on gelatin-
coated dishes in MCDB131 media (Caisson Labs) with 10% fetal bovine serum (Atlanta 
Biologicals), 1% glutamine-penicillin-streptomycin (Invitrogen), 5 U/mL heparin 
(Sigma), and 25 μg/mL endothelial cell growth supplement (Biomedical Technologies).  
Cells were routinely cultured under 5% CO2 at 37°C and passaged at a ratio of 1:4 using 
0.005% trypsin in PBS (Invitrogen).  Cells were used up to passage seven. 
 
Formation of flat collagen gels 
To screen for the preparation condition that best improves the mechanical strength 
of collagen gel, we formed a variety of flat gels.  Every 160 μL of acid-solubilized rat tail 
type I collagen (BD Biosciences) was neutralized with 28 μL of PBS, 20 μL of 10× PBS, 
and 20 μL of 0.2 M NaOH to yield a final collagen concentration of 6.3 mg/mL.  
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Neutralized collagen was pipetted into rectangular polydimethylsiloxane (PDMS) molds 
12 mm × 7 mm in length and width, and allowed to gel for one hour at room temperature.  
The amount of neutralized collagen varied between 100 μL and 600 μL, depending on the 
mechanical test performed (see below).  After gelation, collagen was removed from the 
mold and washed in water for one hour to remove salts, yielding a highly hydrated native 
collagen gel.  To produce crosslinked collagen gel, the native gel was then submerged in 
20 mM genipin in PBS for two hours and washed three times with PBS for ten minutes 
each.  To produce dried collagen gel, the native gel was dehydrated at 37°C under steady 
air flow for two hours, thereby removing over 99% of water, and then rehydrated in PBS.  
The percent dehydration was determined by measuring the weight of collagen gel before 
and after drying.  To produce gel that was both dried and crosslinked, dried gel was 
rehydrated in PBS for thirty minutes, crosslinked in 20 mM genipin for two hours, and 
washed three times with PBS for ten minutes each. 
 
Formation of dense collagen tubes 
Collagen tubes were formed under conditions that yielded highest mechanical 
strength in flat gels (Fig. 2-1).  Briefly, 1 mL of neutralized collagen was pipetted into a 
cylindrical PDMS mold 8 mm in diameter and 12 mm in height, with a core of 0.5- or 1-
mm-diameter glass or stainless steel coated with bovine serum albumin (BSA).  After 
gelling for two hours at room temperature, the collagen gel was removed from the mold, 
but with the rod in place, washed for two hours in water, and dried at 37°C with minimal 
airflow overnight, removing over 99% of water.  The dried collagen tube was rehydrated 
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for thirty minutes in PBS and carefully removed from the rod.  To produce tubes that 
were both dried and crosslinked, the rehydrated collagen tube was placed in 20 mM 
genipin for two hours, and washed three times in PBS for ten minutes each. 
 
Harvesting rat femoral vessels 
To compare the strength of collagen tube-to-vessel anastomosis with that of vessel-
to-vessel anastomosis, we harvested the femoral arteries from five female Sprague-
Dawley rats (Charles River Labs).  Each rat (~250 g) was anesthetized with 5% 
isoflurane and maintained with 2% isoflurane with a nose cone.  The lower abdomen was 
opened, and the femoral artery and vein were exposed by blunt dissection.  The proximal 
and distal ends of the femoral vessels and any small vessel branches were ligated with 
10-0 microsurgical nylon sutures (AROSurgical), and approximately 1 cm lengths of both 
the left and right femoral arteries were dissected.  The rat was euthanized with CO2 while 
still under anesthesia, followed by bilateral thoracotomy.  All surgical procedures were 
performed in accordance with institutional and NIH guidelines for the care and use of 
laboratory animals. 
 
In vitro anastomosis of collagen tubes and/or explanted vessels 
Collagen tubes (1 mm inner diameter) were trimmed to expose a flat edge, and 
were supported on a metal rod during the process of anastomosis (Fig. 2-2A).  Eight 10-0 
sutures were inserted 1.5 mm from the edges of the tube at an even spacing along the  
circumference (Fig. 2-2B).  Once all eight sutures were inserted, simple square knots 
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were used to tie each suture (Fig. 2-2C). 
A similar procedure was used to perform artery-to-artery and artery-to-collagen 
tube anastomoses.  Here, the collagen tubes were 0.5 mm in inner diameter to better 
match the diameter of a femoral artery. 
 
Morphological measurement 
Cross-sections of flat and tubular collagen gels were imaged with an Axiovert 
200M microscope (Zeiss) at 5× magnification.  The thickness of flat collagen gels and 




Ultimate strength was measured for flat gels and intact dense collagen tubes (1 mm 
inner diameter).  The specimen was attached to a force gauge (Jonard) at one end, and 
pulled at the other end at a rate of 1 mm/s until the specimen broke.  The ultimate 
strength was measured as the strength at failure in grams-force (gF).   
Anastomotic strength was measured for anastomosed dense collagen tubes (1 mm 
inner diameter), and for anastomosed dense collagen tubes (0.5 mm inner diameter) and 
rat femoral arteries in a similar manner. 
Suture retention strength was measured for flat gels and intact tubes by first cutting 
one end of the sample with a razor blade to expose a flat edge.  A 10-0 suture was then 
thrown 1.5 mm from the edges and a single square knot was tied.  The suture was secured 
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FIGURE 2-2.  Anastomosis of collagen tubes.  (A) Collagen tubes before anastomosis.  
(B) Suture-threaded collagen tubes.  (C) Completed anastomosis.  A similar process was 
used for anastomosis of collagen tube to an explanted rat femoral artery and for 

















to a force gauge and the specimen was pulled at 1 mm/s.  The maximum load achieved 
was measured in grams-force. 
 
Burst tests 
Burst pressure was measured for intact dense collagen tubes (1 mm inner diameter).  
One end of the tubular sample was cinched onto a 20-gauge needle with 6-0 prolene 
suture and overlap of 3 mm, and the other end was clamped shut with a hemostat.  The 
needle was connected to pressurized nitrogen gas via a plastic tube (inner diameter of 
1/16 inch) that was filled with PBS.  The pressure of the system was gradually increased 
until the sample burst. 
 
Biocompatibility of dense collagen tube 
Dried-and-crosslinked collagen tubes (1 mm inner diameter) were conditioned in 
media overnight.  A suspension of 50 million HUVECs/mL was injected into the lumen 
of the collagen tube.  The tubes were incubated at 37°C for ten minutes to allow cells to 
adhere, and were then washed with fresh media to remove non-adherent cells.  Tubes 
were assessed for confluence and viability of endothelial cells two and seven days after 
seeding.  Seeded tubes were cut open and the inner lumen was stained with 10 µg/mL 
Hoechst 33342, 20 µg/mL calcein AM (Invitrogen), and 10 µM ethidium homodimer-1 
(Invitrogen) for thirty minutes.  Two random fields-of-view that did not include the edge 




In vivo implantation of collagen tubes as interpositional arterial graft 
The right femoral arteries of two Sprague-Dawley rats were exposed using the 
same procedure for vessel harvest.  The blood flow in the femoral artery was temporarily 
stopped with a microvascular clamp.  A 5-mm-long segment of femoral artery was 
explanted, exposing two artery stubs.  Each artery stub was flushed with heparinized 
saline and had adventitia trimmed.  A dried-and-crosslinked collagen tube (0.5 mm inner 
diameter) was anastomosed to the artery stubs with four stay sutures, two on either end, 
followed by twelve interrupted sutures.  After all sixteen sutures were tied, the 
microvascular clamp was released to restore blood flow in the femoral circulation.  The 
ipsilateral epigastric fat pad was used to aid in hemostasis
41
.  Blood flow in the collagen 





All statistical tests were performed using Prism ver. 5 software (Graphpad).  Mann-
Whitney U test was performed for each comparison.  For single pairwise comparisons, a 
p value of less than 0.05 was considered to be statistically significant.  When multiple 
comparisons were made, a p value of less than 0.01 was considered to be statistically 
significant.  Comparisons with the ultimate strength of native or crosslinked gels (which 
were effectively zero) used Wilcoxon’s signed rank test, with a significance condition of 






Native collagen gels did not withstand suturing 
Twenty microliters of neutralized collagen mixture were used to produce flat 
12×7×0.2 mm3 slabs of native collagen gel, with the thickness of 0.2 mm approximating 
that of a human radial arterial wall
43
.  In this highly hydrated state, the collagen gel was 
too fragile to be handled.  Puncturing the gel with the curved needle from a 10-0 suture 
invariably tore apart the entire gel.  Thus, the ultimate tensile strength and suture 
retention strength were effectively zero for native gels (Fig. 2-3A, 2-3B); in only one of 
eight samples could we measure a non-zero suture retention strength. 
 
Drying followed by crosslinking increased strength of flat collagen gels 
Flat collagen gels were used to screen for preparation conditions that yielded the 
greatest mechanical strength.  Flat 0.2-mm-thick collagen gels were compared for 
ultimate strength and suture retention strength in four preparation conditions: native, 
crosslinked, dried, and dried-and-crosslinked.  To obtain similar final thicknesses, 20 μL 
of neutralized collagen mixture were used to produce native and crosslinked gels, and 
400 μL were used to produce dried and dried-and-crosslinked gels.  All gels were tested 
in their rehydrated state.  Even after crosslinking with genipin, collagen gels that had not 
been dried could not be sutured, and their ultimate strength was effectively zero.  Dried 
collagen gels of the same thickness showed significant increase in both ultimate strength 
(19.1 ± 3.9 gF, p = 0.009) and suture retention strength (5.4 ± 2.5 gF, p = 0.0002) 
compared to native gels that had not been dried.  Unlike native gels, dried gels displayed  
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FIGURE 2-3.  Screening for collagen gel treatments that favor suturability.  (A) Ultimate 
strengths and (B) suture retention strengths for flat collagen gels of four gel preparation 
conditions (native, crosslinked, dried, and dried then crosslinked).  (C) Plot of suture 








significant increases in ultimate strength (121.2 ± 40.0 gF, p = 0.0004) and suture 
retention strength (7.9 ± 2.2 gF, p = 0.0006) upon crosslinking (Fig. 2-3A, 2-3B). 
 
Suture retention strength positively correlated with areal concentration of collagen 
To better understand the factors that control suture retention strength, we correlated 
the measured strengths with the areal concentration of collagen (i.e., mass of collagen per 
unit area of scaffold).  Our reasoning was that increasing the density of collagen fibers or 
increasing the thickness of the collagen gel should independently and synergistically 
result in higher suture retention strength.  Areal concentration quantifies the amount of 
collagen that resists suture pull-out, since it equals the density of collagen fibers 
multiplied by the thickness (or wall thickness, in the case of collagen tubes) of the 
sample.  Suture retention strength was measured on dried-and-crosslinked flat gels made 
with 0.2-0.6 mL of neutralized collagen mixture, which corresponded to hydrated gel 
thickness of 0.1-0.5 mm.  Spearman’s correlation between areal concentration and suture 
retention strength yielded a correlation coefficient of 0.75 (p < 0.0001) (Fig. 2-3C).  
 
Drying and crosslinking collagen tubes yielded strengths far greater than those of dried 
tubes 
Based on the results from testing flat gels, collagen tubes of ~1 mm inner diameter 
were prepared under either dried or dried-and-crosslinked condition by molding gels 
around a thin mandrel and then dehydrating (and in some cases, crosslinking) them (Fig. 
2-1, 2-2A).  The wall thickness of these tubes was 0.45 ± 0.19 mm for dried gels and 0.28 
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± 0.10 mm for dried-and-crosslinked gels.  Dried-and-crosslinked tubes yielded 
significantly higher ultimate tensile strength (342.1 ± 15.1 gF vs. 45.7 ± 11.3 gF, p = 
0.0079), suture retention strength (21.0 ± 6.0 gF vs. 11.1 ± 5.1 gF, p = 0.044), 
anastomotic strength (109.1 ± 26.8 gF vs. 16.2 ± 4.1 gF, p = 0.0016), and burst pressure 
(1313 ± 156 mm Hg vs. 63 ± 16 mm Hg, p = 0.029) than for collagen tubes that were 
only dried (Fig. 2-4).  Surprisingly, even though crosslinking caused a doubling of suture 
retention strength, it resulted in nearly order of magnitude increases in ultimate strength, 
anastomotic strength, and burst pressure. 
 
Anastomosis of artery and collagen tube was robust and withheld >80 gF tension 
As the mechanical strengths of dried collagen tubes were significantly lower than 
those of dried-and-crosslinked collagen tubes, only the latter were used for artery-to-
collagen tube anastomosis.  The dimensions of the tubes were adjusted to ~0.5 mm inner 
diameter and ~1 mm outer diameter to better match the size of rat femoral artery (Fig. 2-
5A).  The artery-to-collagen tube anastomotic strength was 81.9 ± 20.6 gF, which was 
lower than the 132.1 ± 19.9 gF we obtained from artery-to-artery anastomosis (p = 0.003) 
(Fig. 2-5C).  Nevertheless, the artery-tube anastomoses displayed strengths that should 
suffice for surgical implantation as an interpositional graft
44
.  We noticed that the artery-
artery anastomosis always failed at one end of the artery (i.e., the artery tore apart; Fig. 2-
5B), while the artery-tube anastomosis always failed with suture tearing through the 
collagen tube (Fig. 2-5A).  This finding indicated that the dried-and-crosslinked collagen 
tube is weaker than the native artery. 
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FIGURE 2-4.  Characterization and comparison of dried and dried-and-crosslinked 
collagen tubes.  (A) Ultimate tensile strengths.  (B) Suture retention strengths.  (C) Burst 










FIGURE 2-5.  Anastomosis of explanted rat femoral arteries and collagen tubes.  (A) 
Artery-tube and (B) artery-artery anastomosis before (top) and after (bottom) failure.  (C) 











Endothelial cells grew to confluence in the lumen of collagen tubes 
The live/dead stain of the lumen of seeded collagen tubes showed that confluent 
endothelial coverage could be achieved 2-3 days after seeding.  Furthermore, confluence 
was maintained up to seven days, and almost all endothelial cells remained viable (Fig. 2-
6).  
 
Dried-and-crosslinked tube successfully withstood implantation and supported blood 
flow 
In a proof-of-principle experiment, we implanted dried-and-crosslinked tubes as 
interpositional grafts in the rat femoral circulation (Fig. 2-7A).  After releasing the 
microvascular clamp, the anastomoses proved to be strong enough to hold arterial flow 
(Fig. 2-7B).  Pulsation was observed when femoral circulation was restored, indicating 
flow in the collagen tube.  Patency was further confirmed by performing the Acland 
“milking” test
42




In the current study, we formed collagen tubes with ≤ 1 mm inner diameter that 
could withstand anastomosis and arterial pressurization and support endothelial cell 
adhesion and growth.  We found that condensing native, hydrated collagen tubes by 
nearly 100-fold through dehydration, followed by rehydration and crosslinking for two 
hours with genipin yielded a scaffold with ultimate tensile strength, burst pressure, and  
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FIGURE 2-6.  Representative nuclear and viability stains of endothelial cells in the 
lumen of collagen tubes at day 2 and day 7.  The photograph on the left shows a collagen 












FIGURE 2-7.  Images of an implanted dried-and-crosslinked collagen tube before (A) 














anastomotic strength comparable to those of a rat femoral artery of similar diameter.  
Furthermore, endothelial cells were able to grow to confluence in these tubes and 
maintain patency for seven days.  To our knowledge, this result represents the first 
collagen-based tubular scaffold of ≤ 1 mm diameter that could be microsurgically 
anastomosed with sufficient strength for implantation in vivo using a standard end-to-end 
suturing technique without a need for external mechanical support. 
Early attempts to form vascular grafts from highly hydrated collagen were not able 
to produce mechanically resilient constructs that could withstand handling and suture, 
even with crosslinking
34, 45
.  Indeed, we were not able to put a suture through native 
collagen gels that were 0.2 mm in thickness without tearing the rest of the gel.  Genipin, a 
less cytotoxic crosslinker than formaldehyde
45
, has been shown to increase the 
mechanical strength of collagen scaffolds and tissue.  Nevertheless, crosslinking native 
gel with genipin did not yield suturable constructs, either. 
Recent studies showed that dense tubular collagen could be produced in hours by 
rolling up a compressed sheet, and that these tubes exhibited mechanical properties 
comparable to those of native vessels
39, 40
.  In the current study, we showed that drying a 
rectangular block of hydrated collagen gel into a flat sheet increased the collagen density 
by ~20-fold, which is comparable to the result obtained by Nazhat and co-workers
39
.  A 
0.2-mm-thick dense collagen sheet yielded ~20 gF in ultimate strength and ~5 gF in 
suture retention strength.  Crosslinking a dried collagen gel further increased ultimate 
strength and suture retention strength to ~120 gF and ~8 gF, respectively.  It should be 
noted that in the current study, the suture retention strengths were measured with 10-0 
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suture instead of the much thicker 4-0 suture used by previous groups.  This difference 
may partly explain why the suture retention strengths we obtained were one order of 
magnitude lower than those reported by other groups (~100 gF). 
In previous studies, hydrated collagen was either compressed or dried into a sheet, 
and was subsequently rolled around a mandrel to produce a tubular construct
39, 40
.  
Despite the claim that there was no void space in rolled sheets, the published micrographs 
appeared to show separation between layers in the collagen
39
.  Chaikof and co-workers 
improved the design by applying recombinant elastin-like protein between collagen 
layers, followed by liquefying and re-gelling the scaffold to fill the void space
40
.  In the 
current study, we dried tubular collagen directly on the mandrel, followed by rehydration.  
The resulting single-layered collagen tubes were monolithic, which proved to be easier to 
suture compared to layered tubes.  In preliminary experiments using multilayered tubes, 
we found that it was often easy to split the layers when puncturing the tube with sutures 
(data not shown).   
Drying a tubular collagen gel as a whole piece yielded higher density than rolling 
up a dried collagen sheet.  While we obtained density of 14 wt.% for flat collagen sheets, 
similar to the result by Nazhat and co-workers
39
, our tubular collagen had density of up to 
30 wt.%.  The difference likely results from constraints on the dehydration process that 
differ between the two gel geometries.  Since the collagen gel contracts perpendicular to a 
contact surface but not along it, the tubular form (which has large outer to inner diameter 
ratio before drying) resulted in higher density increase.  Dried collagen tubes yielded 
ultimate tensile stress (UTS) of 0.21 ± 0.11 MPa, which is comparable to the result 
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obtained by other groups
39, 40
.  The UTS of dried-and-crosslinked tubes was 2.1 ± 0.6 




The burst pressure of dried collagen tubes did not exceed 75 mm Hg, and we 
therefore did not further consider this preparation condition to be suitable for artery-tube 
anastomosis.  On the other hand, dried-and-crosslinked collagen tubes yielded average 
burst pressures of ~1300 mm Hg, which is comparable to the value obtained by Chaikof 
and co-workers
40
.  While this value is still shy of the burst pressure of native arteries 
(which can be as high as 3000 mm Hg
46
), it is close to the value for native vein (~1200 
mm Hg
47
) and more than sufficient to withstand pressure of arterial flow. 
We note that the artery-tube anastomotic strength was lower than that of artery-
artery anastomosis.  Although arteries are considered the gold standard for vascular 
grafts, the value we obtained for artery-tube anastomotic strength should be sufficient for 
microsurgical anastomosis
44
.  Indeed, when dried-and-crosslinked collagen tubes were 
implanted as interpositional graft in the rat femoral circulation, they were able to sustain 
arterial flow, with patency confirmed by the Acland “milking” test and presence of 
pulsation.  
In the current study, we made a few modifications to facilitate end-to-end 
anastomosis of collagen tubes.  In standard microsurgical suture anastomosis, two stay 
sutures are first tied at opposite points on the vessel circumference, and pulled apart to 
create a “fishmouth” field that immobilizes the apposing ends and aids in placement of 
the remaining sutures
48
.  Because the collagen tubes were much less elastic than vessels 
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were, we did not pull the stay sutures and risk dissection of the tube wall.  Instead, the 
collagen tubes were anastomosed as a free graft between artery stubs without extra 
stabilization.  It should also be noted that the native vessels in the current study were 
directly anastomosed to collagen scaffold with suture, which is the current clinical 
standard for graft implantation.  To the best of our knowledge, nearly all other studies that 
claim anastomosis between an engineered scaffold and native vessels used a polymer 
mesh to reinforce the anastomosis
49
, or surgical glue in place of suture
47
, with the study 
by Chaikof and colleagues being an exception
40
.  
Only a few groups have engineered implantable vascular grafts at the ≤ 1 mm scale.  
Narita and co-workers reported making grafts of 0.7 mm inner diameter from poly-ε-
caprolactone
50, 51
.  Nakayama and co-workers developed “biotubes” of 0.7 mm inner 
diameter by using a natural in vivo foreign body encapsulation process
24
.  Yim and co-
workers produced multilayered poly(vinyl alcohol) with 0.9-1.0 outer diameter
52
.  While 
these grafts also achieved mechanical strengths suitable for implantation, the methods of 
Narita and Yim lacked pre-formed endothelial layers, and the method of Nakayama was 
inherently slow (eight weeks to create one tube).  Lack of complete endothelialization 
leads to early thrombus formation and is the major mode of failure of small-caliber 
vascular graft
22
.  In this study, we demonstrated that seeding the collagen tubes with 
endothelial cells led to full endothelial coverage within seven days, as expected given the 
reported biocompatibility of genipin-treated collagen scaffold
53
. 
The logical next step is to implant these endothelialized collagen tubes as 
interpositional grafts in vivo.  Our in vitro, ex vivo, and in vivo data have demonstrated 
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that this scaffold design has sufficient mechanical strength and endothelial coverage for 
implantation.  We believe this design provides a straightforward and promising route to ≤ 
1-mm-diameter vascular grafts for peripheral revascularization, and possibly for 
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Microfluidic approach has been widely used for constructing perfusable vessels in 







, and other materials inside extracellular matrix protein 
such as collagen.  As the sacrificial mold is removed, the empty channels left behind are 
then seeded with endothelial cells to form perfusable vessels.  We have previously made 
single and network of vessels in collagen gel, as well as single vessels in adipocytes-
containing collagen gel, and have successfully perfused the vessels with media 
15, 55, 56
.  
Vessels made this way can be easily viewed at high magnification, and are useful for 
studying vascular permeability and inflammation response 
55, 57
, and may potentially be 
useful for studying diseases such as breast cancer when incorporating other cell types in 
the scaffold 
58
.  Further being able to connect these microfluidic vascular systems to in 
vivo circulation could greatly expand their capability to simulate physiological and 
pathological conditions. 
Several groups have attempted to connect microfluidic vascular systems to in vivo 
circulation.  Radisic and co-workers have implanted “AngioChip” containing vessels 
formed on a polycarbonate backbone into the rat femoral circulation via cannulation 
47
.  
Spector and co-workers implanted vessel containing collagen gel reinforced with 
polymeric mesh via anastomosis 
49
.  While both successfully established blood perfusion, 
in one case, incorporation of polycarbonate backbone between endothelium and 
extracellular matrix did not recapitulate the in vivo vessel structure, in the other case, the 
resulting tissue is very thick, making it difficult to visualize the vessel.  We believe the 
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best result can be achieved by direct anastomosis of vessel containing tissue to the host 
circulation.  However, as the microfluidic vessels are on the order of 100 µm in diameter, 
which is too small and fragile to be anastomosed, it is necessary to incorporate vascular 
pedicles of appropriate size (~1 mm outer diameter to match the rat femoral artery) and 
possessing sufficient mechanical strength to be anastomosed. 
Multiple studies have engineered 1-mm-diameter vessels for implantation.  
Explored methods include electro-spung polymeric scaffold 
50, 52
, decellularized rat tail 
arteries 
59
, and fibrin tubes produced by utilizing foreign body response 
24, 60
.  While these 
methods showed exciting in vivo results in terms of long term patency, the material used 
is difficult to be incorporated into collagen based microfluidic tissue as vascular pedicles.  
To our knowledge, no other group has produced collagen-based, endothelialized vascular 
graft of 1-mm outer diameter that can potentially be used as vascular pedicles in 
microfluidic tissue. 
Recently, we have developed dense collagen tubes of 1 mm outer diameter that 
possess mechanical properties comparable to those of rat femoral arteries 
61
.  We 
demonstrated that endothelial cells were able to reach confluence on these tubes within 
two days after seeding and that the cells remained viable for an additional five days.  We 
also showed in a proof-of-concept experiment that unseeded tubes could withstand 
arterial flow and pressure when implanted as interpositional grafts in the rat femoral 
circulation before they quickly occluded, most likely from the lack of endothelium.  In 
the current study, we further optimized our design to increase the endothelium stability 
under surgical condition.  We report the short-term (~20 minutes) and long-term (~7 
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days) behavior of endothelialized dense collagen tubes that were anastomosed into the rat 
femoral circulation.  We found that, using optimized preparation conditions, the 
endothelial tubes could remain patent and conduct blood flow for one week after 
implantation.     
 
Materials and Methods 
Cell culture and characterization 
Lewis rat aortic endothelial cells (RAOECs; Cell Biologics) were grown on gelatin-
coated tissue culture dishes in a proprietary endothelial cell medium (Cell Biologics).  
Cells were cultured under 5% CO2 at 37°C and passaged at a ratio of 1:4 using 0.005% 
trypsin in phosphate-buffered saline (PBS).  Cells were discarded after passage 8. 
RAOECs were assayed for uptake of acetylated low-density lipoprotein (AcLDL) uptake 
to confirm their endothelial nature.  At confluence, cells were incubated for four hours at 
37°C in endothelial cell media that was supplemented with 5 µg/mL DiI-labeled AcLDL 
(Alfa Aesar) and rinsed with fresh media three times.  Uptake of AcLDL was visualized 
using with a 10×/0.3 Plan-Neofluar objective on a Zeiss Axiovert 200M microscope at 
1300 × 1030 camera resolution and 594 nm excitation. 
 
Formation of endothelialized dense collagen tubes 
Dense collagen tubes were made using a method previously described (Figure 3-1) 
61
.  Briefly, rat tail type I collagen (Corning) was neutralized to pH 7 and final 
concentration 6.6 mg/mL and introduced to a cylindrical mold (6 mm inner diameter) 
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with a 0.5-mm-diameter mandrel in the center.  After gelling for two hours at room 
temperature, the collagen tube was removed from the mold and washed in deionized 
water for one hour to remove excess salt.  It was then placed on a rotisserie and 
dehydrated overnight with constant rotation, removing ≥99% water.   
The dried collagen tubes were then crosslinked with various concentrations of 
genipin (5, 10, 15, or 20 mM in PBS; Wako) for two hours at room temperature, washed 
three times for one hour each in PBS, and conditioned in media overnight. 
RAOECs were suspended in culture media at 2 million cells/mL.  Conditioned dense 
collagen tubes were cut into 4- to 5-mm-long segments and submerged in cell suspension.  
Tubes were gently milked with tweezers to ensure that the cell suspension filled the 
lumen.  While still submerged in cell suspension, the tubes were tumbled for one hour at 
37ºC.  Seeded tubes were washed once with media, placed in separate wells of a 24-well 
plate that had been pre-coated with Pluronic F68 (5 mg/mL in PBS for one hour; Sigma)  
to prevent adhesion, and cultured under static conditions with 0.5 mL culture media.   
Culture medium was replaced every two days for up to ten days. 
 
Viability assay 
After being cultured for three days, seeded tubes were incubated in media 
supplemented with 10 µg/mL calcein AM and 5 µg/mL Hoechst 33342 (both from 
Invitrogen) for thirty minutes.  Tubes were then cut open lengthwise, and live cells and 



















Characterization of endothelial stability in vitro 
After being cultured for three or ten days, endothelialized collagen tubes that were 
crosslinked with 5, 10, 15, or 20 mM genipin were gently squeezed with #5 tweezers 
twenty times to mimic surgical handling.  Squeezed tubes were gently flushed once in 
PBS to remove any detached endothelial cells.  Tubes were fixed in formalin (Fisher) for 
thirty minutes and washed three times for ten minutes each in PBS.  Nuclei were stained 
with 5 µg/mL Hoechst 33342 for ten minutes.  Tubes were then cut open lengthwise, and 
the nuclei in the lumen were visualized at 350 nm excitation.  Tubes that possessed intact 
endothelium throughout the lumen (not counting slight damage to the edge of the tube 
from handling with tweezers) were considered “undamaged”.   
 
In vitro hemostasis assay 
In vitro hemostasis assays were performed on collagen tubes that were crosslinked 
with 5, 10, or 15 mM genipin and seeded with RAOECs.  Immediately after cell seeding, 
an 8- to 10-mm-long segment of PE10 tubing (Braintree Scientific) was inserted 1 mm 
into the lumen of the collagen tube on either end and cinched with 10-0 sutures (ARO 
Surgical).  After culturing for ten days, seeded tubes were connected to a peristaltic pump 
with PE50 tubing and perfused with heparinized (20 U/mL) Lewis rat blood at ~0.3 
mL/min.  Perfusion was conducted for up to thirty minutes or until perfusion stopped, 
whichever came first.  Tubes were then disconnected from the perfusion system and 
gently flushed with PBS to wash out any blood from the lumen.  Tubes were stood 
upright to visualize the lumen using a dissection microscope at 25× magnification.  
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Unseeded tubes that were crosslinked with 5 mM genipin served as controls. 
 
Characterization of mechanical properties 
Mechanical properties of collagen tubes that were crosslinked with 5 mM genipin 
and cultured for ten days after seeding were characterized using the same procedures as 
described previously 
61
.  Briefly, to measure ultimate tensile stress, we attached seeded 
collagen tubes to a force gauge (Jonard) and pulled at 1 mm/s until the collagen tube 
fractured.  The measured force was divided by the initial cross-sectional area of the 
collagen wall to calculate ultimate tensile stress. 
To measure burst pressure and compliance, we cinched seeded collagen tubes onto a 25-
gauge needle at one end and closed the other end with a 6-0 prolene suture (Ethicon).  
The needle was connected to pressurized nitrogen gas.  The pressure was increased from 
0 to 380 mm Hg in three increments, and the compliance was calculated by linear 
regression between pressure and percentage change in outer diameter.  Burst pressure was 
obtained by gradually increasing the pressure of the system until the sample failed. 
All mechanical properties were measured at room temperature. 
 
In vivo implantation of seeded dense collagen tubes 
All in vivo procedures were performed in accordance with institutional guidelines 
and the National Institutes of Health Guidelines for the Care and Use of Laboratory 
Animals.  Twenty-two tubes were implanted, with one tube per animal.  For each 
implantation, a female Lewis rat (~250 g; Charles River) was anesthetized with 4% 
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isoflurane and maintained at 1.5% isoflurane for the duration of the surgery (~4 hrs).  
Buprenex (0.1 mg/kg) was administered thirty minutes before incision.  The lower 
abdomen was opened, and the left femoral artery and vein were liberated.  Blood flow in 
the femoral artery was temporarily ceased with microsurgical clamp, and a 2-mm-long 
segment of femoral artery was excised, leaving a 1-mm-long artery stub at either end.  
The artery stubs were flushed with 100 U/mL heparin and trimmed of adventitia.  A 
seeded dense collagen tube (kept at 37°C up to this point) was anastomosed end-to-end to 
the femoral artery with eight interrupted 10-0 sutures on either end, as previously 
described 
61
.  After all sixteen sutures were completed, the microvascular clamp was 
released to restore blood flow.  Acute patency of the implanted collagen tubes were 
monitored for up to twenty minutes by performing a “milking test” as described by 
Acland
42
.  If the implanted tube remained patent for up to twenty minutes after 
reestablishing blood flow, then the wound was closed with surgical clips (Braintree 
Scientific); if not, the rat was euthanized by CO2 while still under anesthesia, followed by 
bilateral thoracotomy.  After wound closure, another 0.1 mg/kg of Buprenex was 
administered.  The rat was removed from anesthesia thirty minutes after Buprenex 
injection.  Rats with patent tubes were kept for up to seven days after surgery, with 0.05 
mg/kg Buprenex administration twice daily for the first two days, and as needed 
thereafter.  On up to the seventh day, the surgical site was re-opened and the patency of 
the implanted tube was confirmed again with the Acland test.  The tube was then excised 
with 1- to 2-mm-long femoral artery stubs on both ends and fixed with formalin for 
further characterization.  The rat was then euthanized with CO2 while still under 
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anesthesia, followed by bilateral thoracotomy.   
In three control rats, a 5-mm segment of femoral artery was excised and immediately 
replanted in  its original position with eight sutures on each end.  Wounds were closed 
and rats were maintained for seven days.  Implanted arteries were then harvested and 
fixed with formalin for characterization.   
In total, implants of endothelialized tubes or vessels were performed on twenty-five 
animals (Table 1).  Explantation time was chosen to be seven days, because this time is 




Histological evaluation of the implanted tubes 
Two tubes that were crosslinked with 20 mM genipin and cultured for three days 
(harvested three and five days after implantation), three tubes that were crosslinked with 
5 mM genipin and cultured for ten days (all harvested seven days after implantation), and 
three replanted femoral arteries (all harvested seven days after replantation) were 
histologically evaluated.  Tissues were fixed in formalin (10%, neutral buffered), 
embedded in paraffin, and sectioned.  
Russel-Movat pentachrome staining kit (American MasterTech) was used in 
accordance with the manufacturer’s instructions for the microscopic structural evaluation 
of all implanted collagen tubes and sham control anastomoses (i.e., artery replants).  
Structures that identified as elastic fibers stained dark blue; as collagen, yellow; as 








   
Group Sham control A B C D E 
Culture duration n.a. 3 days 3 days 3 days 5 days 10 days 
Genipin 
concentration n.a. 20 mM 10 mM 5 mM 5 mM 5 mM 
Number of surgeries 3 11 1 1 1 8 
n.a., not applicable 
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Immunohistochemistry was also performed to evaluate the presence of endothelium 
in implanted tubes that were crosslinked with 5 mM genipin and in sham control 
anastomoses.  A total of eight random sections per rat were deparaffinized and rehydrated 
in decreasing alcohol series.  Endogenous peroxidase activity was quenched by 1% H2O2 
and sections were washed in PBS.  Protein blocking was performed with horse serum and 
sections were incubated for one hour with mouse anti-rat CD31 monoclonal antibody 
(clone TLD-3A12; Invitrogen) at a concentration of 1:100 dilution.  Mouse IgG (20 
µg/mL) as well as omitting the primary or secondary antibodies were used as technical 
controls.  After PBS washes, horseradish peroxidase-conjugated horse anti-mouse IgG 
(ImmPRESS polymer detection kit; Vector Labs) was applied for thirty minutes.  
Sections were washed in PBS and enzyme substrate 3,3’-diaminobenzidine-nickel for ten 
minutes and counterstaining with Nuclear Fast Red (Vector Labs) was applied, followed 
by dehydration, clearing, and mounting.  All conditions were processed simultaneously.  
Images were captured randomly by a Nikon Eclipse 50i microscope at.  Histological 
evaluation was done by an expert histo-biologist (E.B.-S.). 
 
Statistical analysis 
All statistical tests were performed with Prism version 6 software (Graphpad).  Chi-
squared test for trend was used to compare the effect of different crosslinking conditions 
on endothelial stability (cultured for either three or ten days after seeding) and hemostasis 
(cultured for ten days after seeding).  Fisher’s exact test was used to compare the effect of 
culture time on the stability of endothelium.  Measured ultimate tensile stress, burst 
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pressure, and compliance were reported as mean ± standard deviation.  A value of p < 
0.05 was considered statistically significant. 
 
Results 
Rat aortic endothelial cells reached confluence in dense collagen tubes 
Previously, we seeded dense collagen tubes with human umbilical vein endothelial 
cells (HUVECs) and showed that these cells reached confluence in two days and 
remained viable for up to seven days 
61
.  In the current study, we seeded collagen tubes 
with endothelial cells from Lewis (inbred) rats, so that the resulting tubes could be 
implanted in immunocompetent hosts without risk of rejection.  After culturing for three 
days post-seeding, live stain of the lumen showed that seeded RAOECs remained viable  
and had reached confluence (Figure 3-2A). 
 
Unoptimized crosslinking and culturing method led to low patency rate in vivo 
Initially, dense collagen tubes were crosslinked with 20 mM genipin and cultured 
for three days after seeding with RAOECs.  This procedure was based on our previous 
results with HUVEC-seeded tubes 
61
.  While this method yielded tubes with confluent 
endothelium (Figure 3-2A) and with sufficient mechanical strength to withstand suture 
anastomosis and arterial flow (Figure 3-2B), it resulted in extremely poor patency rate 
after anastomosis.  Only two out of eleven implanted tubes remained patent at twenty 
minutes after re-establishing blood flow.  Of these two tubes, only one remained patent 
for five days after implantation.  Moreover, histological staining of this tube showed that 
 
 52 
thrombus formed inside the lumen (Figure 3-2C).  The other tube was not patent at three 
days after surgery, and its lumen was completely occluded by thrombus (Figure 3-2D).  
These in vivo findings suggested that although an endothelium was well-formed on tubes 
in vitro, but it was lost and/or thrombogenic after implantation in vivo. 
 
Endothelial stability depends on crosslinking and culturing conditions in vitro 
We noticed that implanted tubes that were crosslinked with 20 mM genipin 
developed cracks in their walls (Figure 3-2C, D), which most likely resulted from 
surgical handling.  This observation suggested that the collagen gels might be too brittle.  
We therefore investigated whether lowering the stiffness of the collagen gel might 
improve the stability of the endothelium.  In addition, we examined whether culturing 
endothelial cells for a longer time after seeding also led to improvement.  We made dense 
collagen tubes that were crosslinked with 5, 10, 15, or 20 mM genipin, and cultured 
statically for either three or ten days.  Tubes were then gently squeezed twenty times to 
mimic surgical handling.  We observed that tubes that were made with the original 
crosslinking (20 mM genipin) and culturing (three days) conditions resulted in damaged 
endothelium after squeezing in all samples tested (Figure 3-3A, bottom).  Endothelial 
stability improved as the concentration of genipin was lowered.  The cell layer in tubes 
that were crosslinked with 5 mM genipin remained intact in four out of nine samples 
tested.   
Endothelial stability was further improved by increasing the culturing time.  After 
ten days of culturing, intact endothelium was present in seven out of nine, six out of nine,  
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FIGURE 3-2.  Implantation of seeded dense collagen tubes (crosslinked with 20 mM 
genipin, cultured for three days).  A) Live (green) and nuclei (blue) stain of seeded 
collagen tube.  B) Endothelialized tube as interpositional graft on day 0.  C) Histological 
stain of a partially clotted tube explanted on day 5.  D) Histological stain of a completely 













and six out of eight samples tested, crosslinked with 5, 10, and 15 mM genipin, 
respectively.  Tubes that were crosslinked with 20 mM genipin still resulted in damaged 
endothelium in all samples even after ten days of culturing (Figure 3-3A, B).  These 
results indicated that decreasing genipin concentration improved the stability of 
endothelium at both three-day (p = 0.046) and ten-day (p = 0.023) culture period.  For 
tubes that were crosslinked with 5, 10, or 15 mM genipin, increasing culture period from 
three days to ten days also improved endothelial stability (p = 0.012). 
 
Crosslinking condition does not affect the anti-thrombotic property of endothelium in 
vitro 
To test if the crosslinking condition affected the endothelium’s ability to prevent 
clotting, we connected collagen tubes (crosslinked with 5, 10, or 15 mM genipin, seeded 
with RAOECs, and cultured for ten days) to a peristaltic pump and perfused them with 
partially heparinized rat blood (Figure 3-4A).  Since tubes that were crosslinked with 20 
mM genipin did not yield stable endothelium after seeding, this condition was not tested 
for hemostasis.  Hemostasis was performed on tubes in which PE10 tubing had been 
inserted at both ends one day after seeding and left undisturbed for the remaining culture 
duration to minimize any damage to the endothelium upon connecting to the pump.  In 
unseeded collagen tubes (crosslinked with 5 mM genipin) that served as a control group, 
perfusion lasted for 10-20 minutes before thrombus formed in 4 out of 5 samples tested, 
consistent with the low patency rates observed in previous work 
61
.  In seeded collagen 
tubes (n = 6 for each genipin concentration), patency lasted for at least thirty minutes  
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FIGURE 3-3.  In vitro stability of endothelium on collagen tubes with different seeding 
and crosslinking conditions.  A) Tubes that were cultured for three days showing majority 
outcome.  B) Tubes that were cultured for ten days showing majority outcome.  C) 










FIGURE 3-4.  In vitro hemostasis assay in seeded collagen tubes.  A) Seeded collagen 
tube connected to perfusion via PE10 tubing.  B) Lumen of collagen tubes (crosslinked 
with 5 mM without endothelial cell seeding and crosslinked with 5, 10, and 15 mM with 











(when perfusion was terminated), and no clot was observed in the lumen (p = 0.0017 
compared to unseeded tubes; Figure 3-4B). 
 
Tubes with optimized gelling and seeding conditions possess sufficient mechanical 
strength for implantation 
Our in vitro results suggested that dense collagen tubes that were crosslinked with 5 mM 
genipin and cultured for ten days would offer the best condition to obtain functional 
endothelium after seeding, culture, and implantation.  To determine whether the lower 
degree of crosslinking would compromise the mechanical properties of these tubes, we 
tested tubes that were crosslinked with 5 mM genipin, seeded, and maintained for ten 
days in rat endothelial cell media.  The ultimate tensile stress was 2.4 ± 0.6 MPa (n = 3), 
the burst pressure was 1051 ± 79 mm Hg (n = 3), and compliance was 3.2 ± 0.8%/100 
mm Hg (n = 3).  These values compare favorably to values for tubes that were 
crosslinked with 20 mM genipin (2.1 ± 0.6 MPa for ultimate tensile stress, 1313 ± 156 
mm Hg for burst pressure, and 1.7 ± 0.4%/100 mm Hg for compliance) 
61
.  These 
comparable values indicated that dense collagen tubes that were crosslinked with 5 mM 
genipin possessed enough mechanical strength to withstand suture anastomosis and 
arterial perfusion. 
 
Implanted seeded dense collagen tubes conducted blood flow for up to seven days in vivo 
Of the eight implanted tubes that were crosslinked with 5 mM genipin and cultured 
for ten days to maintain a stable endothelium, three remained patent at twenty minutes 
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after implantation and re-establishment of femoral circulation in vivo.  Importantly, all 
three tubes maintained stability without rejection, and were patent when the surgical sites 
were re-opened after seven days.  A thin layer of small blood vessels formed on the outer 
surface of the implanted tubes, which were well-integrated with the surrounding tissue 
(Figure 3-5A).  In contrast, implants of tubes that were crosslinked with 10 mM genipin 
or that were cultured for three or five days led to immediate thrombosis. 
Low- (10×) and high-magnification (40×) pentachrome-stained images revealed 
that the lumens of sham surgery and implanted tubes (5 mM genipin, 10-day culture) 
remained patent without thrombosis or infection.  The sham surgery exhibited the same 
histological characteristics; the intima, media, and adventitia layers were mostly 
undisturbed (Figure 3-5B).  As a repair process, loose reddish granulation tissue occurred 
at the surgery suture sites (Figure 3-5B, arrow).  All three explanted tubes also showed 
similar level of remodeling with granulation tissue formation on the inside and outside 
surface of the tube (Figure 3-5C), as well as on the proximal and distal artery stubs at the 
anastomosis site.  The inner surface of the tubes showed different stage of collagen 
remodeling of the tubes with granulation tissue, which was specific for the inflammatory 
phase of repair with fibrinogen deposition, platelet aggregation and some neutrophil and 
macrophage infiltration.  A few fibroblasts also appeared to be present (Figure 3-5C).  
The outer surface of the implanted tubes exhibited remodeling with similar histological 
characteristics as the inner surface.  In addition, newly formed capillaries were present in 
the granulation tissue on the outer surface.   
Compared to sham surgery (Figure 3-5D, arrow), immunohistochemistry for CD31  
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FIGURE 3-5.  Histological characterization of patent endothelialized tubes seven days 
after implantation.  A) Implanted tube at day 7 while still connected to femoral 
circulation.  B-D) Pentachrome-stained images of native femoral artery (B), sham 
replanted artery (C), and implanted tube (D).  E-F) CD31-stained images of replanted 
artery (E) and implanted tube (F).  CD31 is dark brownish (arrows) and nuclei are pink.  











revealed increased expression in implanted tubes (Figure 3-5E, right arrow).  It should be 
noted that, on the inner surface, CD31 is expressed not only by the endothelial cell layer 
but also by platelets and monocytes.  On the outer surface, the endothelial layers of the 
newly formed capillaries were positively labeled (Figure 3-5E, left arrow). 
 It should be noted that the diameter of explanted artery from sham surgery is ~0.6 
mm (Figure 3-5B,D), which is smaller than that of explanted collagen tubes (diameter ~1 
mm, Figure 3-5C,E).  This is due to the contraction of arteries upon removal of arterial 
pressure during explantation.  Collagen tubes are more rigid compared to arteries and do 
not contract during explantation.  
 
Discussion 
In this study, we implanted 1-mm outer diameter endothelialized dense collagen tubes 
into the rat femoral circulation and demonstrated that it is possible for these tubes to 
remain patent and conduct blood flow for up to seven days.  We tested the endothelial 
stability in vitro by simulating surgical handling, and found that crosslinking at lower 
genipin concentration and increasing culture duration after seeding improved endothelial 
stability.  These results build upon and extend our previous work, in which we showed 
that dense collagen tubes produced by dehydrating and crosslinking native collagen could 
be endothelialized and possessed sufficient mechanical strength to withstand anastomosis 
and arterial perfusion 
61
. 
In the current study, we observed that collagen tubes crosslinked with 20 mM 
genipin and cultured for three days after seeding (the same conditions used in the 
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previous study) led to very low immediate patency rate after implantation.  Subsequent in 
vitro tests to mimic surgical handling revealed that the endothelium detached after even 
very gentle squeezing, which explains the observed low patency rate.  Cell detachment 
often occurred in large sheets, rather than as individual cells.  The frequency of 
detachment was less in tubes that were crosslinked with lower concentrations of genipin 
and that were cultured for longer times after endothelial cell seeding.  As tubes 
crosslinked with lower genipin concentration exhibited higher compliance, one 
explanation for the improved cell stability could be that in the less-crosslinked tubes, the 
endothelium experienced smaller stress with the same amount of deformation and 
therefore was less likely to detach.  Also, in tubes crosslinked with high genipin 
concentration, small cracks in the wall were sometimes observed during anastomosis, 
which may further damage the endothelium.  Another possibility is that, with longer 
culture period after seeding, seeded endothelial cells secreted adhesive extracellular 
matrix proteins, which would improve the stability of endothelium 
62
. 
While tubes that were formed under optimized conditions (crosslinked with 5 mM 
genipin and cultured for ten days after seeding) showed relatively high endothelial 
stability in vitro (~75% intact endothelium after simulated surgical handling), the 
immediate patency rate of these optimized tubes in vivo was lower (~40%).  A possible 
explanation of the discrepancy between in vitro and in vivo results is that during actual 
surgery, the seeded tubes were exposed to room temperature in a serum-free environment 
for 2-2 hours, which may adversely affect the endothelial stability.  Furthermore, the 
actual surgical handling was more rigorous compared to the in vitro test, which would 
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cause more damage to the endothelium. 
Nevertheless, tubes that were patent in the short-term exhibited no thrombosis or 
infection and survived up to seven days.  Importantly, the explanted tubes showed a 
similar level of remodeling with granulation tissue formation inside and outside of the 
tube surface.  Blood cells and fibroblasts in the inner surface of the tubes may have 
initiated the collagen remodeling of the tube at the inner surface.  The outer surface of the 
implanted tubes also triggered remodeling with similar histological characteristics as the 
inner surface with the exception that there were newly formed capillaries in the outer 
granulation tissue.  These microscopic processes imply that further tube remodeling could 
lead to even longer survival of the construct-vessel interface without complete thrombus 
formation.  This possibility is supported by the CD31 immunohistochemistry since the 
endothelial layer of the newly formed capillaries were also positively labeled at the outer 
surface of the collagen tubes.  An increase in the expression of CD31 in the inside of the 
collagen tubes compared to the controls was also observed.  Our stain could not 
determine whether the CD31-expressing cells were the original RAOECs lining the tubes, 
host rat-derived ECs that migrated from native femoral artery, and/or rat-derived platelets 
and monocytes.  We speculate that the 5 mM genipin crosslinking provided the best 
stiffness of the tubes that can withstand the in vivo fluid shear stresses and maintain 
endothelial function.  It is also possible, however, that the remodeling response from 
platelets and monocytes may be superior in the 5 mM genipin-treated tubes. 
Regardless of the underlying mechanism, our results are the first to show that it is 
possible to achieve long-term (seven days) patency with endothelialized dense collagen 
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tubes as interpositional microsurgical grafts in the rat femoral circulation.  Obviously, the 
immediate patency of ~40% needs to be improved for this design to be clinically viable.  
Possible ways to improve endothelial stability include reducing the wall thickness of the 
collagen tube (while still maintaining sufficient strength) to further increase compliance, 
coating the tube lumen with collagen type IV for stronger endothelial cell adherence, and 
culturing seeded tubes under flow conditions.  We believe that this method to engineer 1-
mm-diameter vascular grafts has promising potential as vascular pedicles for bridging 
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Large soft-tissue defects often accompany traumatic injury, tumor resection, or 
diabetic foot.  The current gold standard for reconstruction of these defects is autologous 
tissue transfer of adipocutaneous flaps 
63
.  This technique is limited by tissue availability 
and may result in donor-site morbidity.  The engineering of a stable and functional 




Studies have shown that immediate perfusion is absolutely required for survival of 
free flaps and transplanted tissue, unless the tissue is extremely thin 
10, 11
.  Free fat 
grafting by lipoinjection, which disrupts the native adipose vasculature and cannot 
establish immediate perfusion, often fails to maintain volume over time 
65, 66
.  Therefore, 
it is crucial for engineered adipose tissue to not only have a preformed vasculature, but 
one that is perfused.  Most studies to engineer vascularized fat tissue have employed a 
combination of angiogenic and adipogenic growth factors, a suspension of endothelial 
cells and adipocytes and/or adipocyte progenitors, and an appropriate scaffold 
67-69
.  The 
vasculature in these engineered tissues forms by angiogenesis and/or vasculogenesis, 
which typically require one or more weeks and can yield a poorly organized 
microvascular network.  Moreover, the small diameter of these microvessels makes 
cannulation and surgical anastomosis impossible, and it is unclear how to establish 
perfusion during tissue maturation in vitro and upon grafting in vivo.  Insertion of an 
arteriovenous bundle into the developing construct can provide a vascular pedicle for 





With few exceptions, studies of engineered adipose tissue have focused primarily 
on characterizing the structure of the tissue histologically and have confirmed the 
presence of adipocytes by staining with lipid markers such as Oil Red O 
71
.  Along with 
its structural role, however, adipose tissue plays critical metabolic and endocrine roles 
that depend on signals from adjacent endothelial cells that line their lumens 
72
.  Insulin 
has been shown to upregulate lipogenesis both by increasing uptake of free fatty acid 
73
 
and by increasing conversion of triacylglycerol into fatty acid by lipoprotein lipase that is 
expressed on the surface of endothelial cells 
74
.  Conversely, β-adrenergic agonists such 
as epinephrine have been shown to upregulate lipolysis by stimulating the activity of 
hormone-sensitive lipase 
75
.  It is important to demonstrate that engineered adipose tissue 
responds to lipoactive hormones in a physiologically relevant manner 
76
. 
The objective of the current study was to engineer a vascularized adipose tissue that 
could be immediately and constantly perfused and that demonstrated lipoactivity.  The 
methods described here built upon previously described techniques to vascularize 
microfluidic collagen scaffolds 
55
, and yielded a “fundamental unit” of adipose tissue that 
contained one microvessel that perfused an adipocyte-laden collagen gel.  We showed 
that the microvessel within the engineered adipose tissue possessed good barrier function, 









Mouse 3T3-L1 preadipocytes (ATCC) were grown in high-glucose DMEM 
(Invitrogen) supplemented with 10% heat-inactivated fetal bovine serum (FBS; Atlanta 
Biologicals) and 1% glutamine-penicillin-streptomycin (GPS) (“basal medium”).  The 
3T3-L1 cells were routinely passaged at 1:10 ratio and were used up to passage nine. 
To differentiate 3T3-L1 cells, we switched cultures two days post-confluence, to 
“differentiation medium”: basal medium supplemented with 0.25 µM dexamethasone, 2 
µM rosiglitazone, 10 µg/mL insulin, 0.5 mM 3-isobutyl-1-methylxanthine, and 0.2 mM 
ascorbic acid 2-phosphate (all from Sigma) 
77
.  After another two days, differentiation 
medium was replaced with “maintenance medium”: basal medium supplemented with 10 
µg/mL insulin only.   
Human dermal microvascular endothelial cells (ECs; PromoCell) were grown on 
gelatin-coated dishes in MCDB131 medium (Caisson) that was supplemented with 10% 
FBS, 1% GPS, 1 µg/mL hydrocortisone (Sigma), 80 µM dibutyryl cyclic AMP (Sigma), 
25 µg/mL endothelial cell growth supplement (Alfa Aesar), 2 U/mL heparin (Sigma), and 
0.2 mM ascorbic acid 2-phosphate (“EC culture medium”).  ECs were routinely passaged 
at a 1:4 ratio and were used up to passage nine. 
 
Formation of vascularized adipose tissues 
Adipose tissues that contained a single microvessel (n = 57) were formed using a 
modified procedure from a previous study 
55
.  Briefly, a stainless steel needle of 120 µm 
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in diameter (Seirin) was positioned at the center of a 1 mm × 1 mm × 7 mm chamber in 
silicone (PDMS) mold.  Rat tail type I collagen (diluted to 6 mg/mL before mixing with 
cells; Corning) was neutralized to pH 7.  Confluent 3T3-L1 cells were trypsinized 6-7 
days after start of differentiation and centrifuged at ~120 g for three minutes, yielding a 
cell pellet that was ~15 µL. The cell pellet was gently mixed with 375 µL neutralized 
collagen to yield a density of ~10
6
 cells/mL, and was gelled for thirty minutes at room 
temperature in the chamber around the needle; the final concentration of collagen was 
~5.8 mg/mL.  The needle was removed, and the resulting channel was then seeded with 
ECs.  Perfusion was set up in the microscale tissue by connecting each end of the channel 
to a reservoir of EC culture media that was supplemented with 3% dextran (70 kDa; 
Sigma) (“perfusion media”).  A pressure difference of 4.5 cm H2O was maintained for up 
to seven days.  Perfused adipose tissues were kept at 37°C in 5% CO2 and refed twice 
daily (figure 4-1).  As a control, some gels (n = 8) were formed and vascularized without 
the addition of adipocytes. 
To form larger tissues (n = 17), we used wider chambers (1 mm × 11 mm × 6 mm) 
to hold the needle; the needle was placed 0.5 mm away from one edge of the chamber 







Hydraulic permeability and stiffness assays 
To measure the hydraulic permeability of adipocyte-containing and cell-free 
collagen gels, we gelled collagen with and without 10
6
 3T3-L1 cells/mL in PDMS molds  
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FIGURE 4-1.  Schematic diagram of the formation of microscale adipose tissues that 












to form 1 mm × 1 mm × 7 mm solid gels.  On days 1 through 5 after gelling, perfusion 
media that was supplemented with 10 µg/mL insulin and 0.5 mg/mL Intralipid (Sigma) 
was allowed to flow through the gel for two hours under an applied pressure difference of 
2-1.1 cm H2O.  The hydraulic permeability coefficient k was calculated using equation 1, 
where Q is the flow rate of the media, A is the cross-sectional area of the gel, ΔP is the 






 (equation 1) 
To measure the stiffness of adipocyte-containing and cell-free collagen gels, we formed 
disc-shaped collagen gels with and without 10
6
 3T3-L1 cells/mL in a cylindrical mold 
that was 6 mm in diameter and 2 mm in height.  Gels were again kept in perfusion media 
that was supplemented with 10 µg/mL insulin and 0.5 mg/mL Intralipid.  On days 1, 3, 
and 5 after gelling, each gel was submerged horizontally in phosphate buffered saline 
(PBS), and an aluminum ball with diameter of 1.6 mm (Precision Balls) was placed on 
the upper surface of the collagen.  After one hour, the indentation of the aluminum ball 
was measured, and the stiffness was calculated as indentation modulus using equation 2, 
where R and ρ are the radius and density of the aluminum ball, respectively, 𝜌𝑃𝐵𝑆 is the 











  (equation 2) 
 
Lipogenesis and lipolysis assay 
After vascularized adipose tissues were perfused for one day, the perfusion media 
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was supplemented with 10 µg/mL insulin and 0.5 mg/mL Intralipid.  Intralipid is an 
emulsion of lipid that is used for parenteral nutrition and has been shown to increase the 
accumulation of lipids in adipocytes in planar culture 
79
.  After another four days of 
perfusion (i.e., on day 5 of perfusion), tissues were then switched to perfusion with 
insulin- and Intralipid-free media with or without 10 µM epinephrine for an additional 
four days (i.e., to day 9 of perfusion).  Phase-contrast images were taken on days 1, 3, 5, 
7, and 9 of perfusion, and the lipid droplet area per cell was measured manually for 30-40 
adipocytes per tissue.  The results were compared between tissues with or without 
insulin/Intralipid for days 2-5 and between tissues with or without epinephrine for days 5-
9.  Images were obtained with a 10×/0.30 Plan-Neofluar objective on a Zeiss Axiovert 
200M microscope at 1300×1030 camera resolution.  All lipid droplet measurements were 
performed in a blinded manner. 
Wide tissues that contained 10
6
 or 1.5 × 10
6
 3T3-L1 cells/mL and a single vessel 
were perfused for seven days, the last six with media that was supplemented with 10 
µg/mL insulin and 0.5 mg/mL Intralipid.  On days 1, 3, 5, and 7 of perfusion, phase-
contrast images of adipocytes that were at different distances from the vessel (0-1 mm, 2-
2 mm, etc.) were taken, and the lipid droplet area per cell of 30-40 cells were measured 
for each distance range. 
 
Vascular permeability assay 
Macromolecular permeability of the endothelium in vascularized tissue was 
measured using a previous method 
80
.  Briefly, after 4-4 days of perfusion, media in the 
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upper reservoir was replaced with perfusion media that was supplemented with 50 µg/mL 
Alexa Fluor 594-conjugated bovine serum albumin (BSA) and 20 µg/mL Alexa Fluor 
488-conjugated 10 kDa dextran (both from Invitrogen).  The tissue was placed in an 
environmental chamber at 37°C, and time-lapse images were captured every minute for 
thirty minutes in both red and green channels.  Average gray values for the time-lapse 
images were measured using ImageJ and recorded.  Permeability coefficients were 





Adipocyte viability assay 
Adipose tissues were disconnected from tubing after three days of perfusion.  
Perfusion media containing 10 µg/mL calcein AM, 10 µM ethidium homodimer, and 5 
µg/mL Hoechst 33342 (all from Invitrogen) was added to the wells on either side of the 
tissue, allowed to flow through the vessel, and incubated for thirty minutes at 37°C.  To 
first visualize viability of endothelial cells, we captured images in green, red, and blue 
channels for live cells, dead cells, and nuclei, respectively, while focusing at the 
microvessel.  The tissues were then carefully taken out of the PDMS mold and 
submerged in media containing live/dead stain for another thirty minutes.  To visualize 
live and dead adipocytes, we captured images using the same excitation wavelengths 





After one day of perfusion, the engineered tissues were fixed by perfusion with 4% 
paraformaldehyde (15 min, 20°C).  Each tissue was then blocked and permeabilized with 
5% goat serum and 0.5% Triton X-100 in PBS (“blocking buffer”) for at least one hour.  
To stain for the endothelial junctional marker CD31, we perfused the permeabilized 
tissue with 5 µg/mL mouse anti-human CD31 (clone WM-59; Sigma) for one hour, 
flushed the tissue three times for twenty minutes each with blocking buffer, perfused the 
tissue with 10 µg/mL Alexa Fluor 488-conjugated goat anti-mouse IgG (Invitrogen) for 
one hour, and flushed the tissue three times for twenty minutes each with blocking buffer.  
The tissue was then taken out of the PDMS chamber and stained for lipid droplets with 
25 µg/mL Nile Red (Sigma).  Stained tissue was imaged in green and red channels for 
visualization of CD31 and lipid droplets, respectively.  To acquire cross-sectional views, 
we embedded the stained tissue in 4% agarose, sliced it into 0.5- to 1-mm-thick pieces, 
and imaged at the lumen.   
 
Statistics 
All statistical tests were performed using Graphpad Prism ver. 6.  Kruskal-Wallis 
test with Dunn’s multiple comparison was used to compare solute selectivities or 
permeability coefficients to BSA and dextran.  Two-way ANOVA with Bonferroni post-
test was used to compare hydraulic permeabilities, indentation moduli, or lipid droplet 
areas per cell.  To determine if hydraulic permeabilities and indentation moduli varied 
over time, we performed a linear fit on data collected on different days and the slope was 
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compared to zero.  A value of p < 0.05 was considered statistically significant.  Data are 
listed as means ± standard deviation. 
 
Results 
Addition of adipocytes increases hydraulic permeability and decreases stiffness of 
collagen gels 
Compared to bare collagen gels, adipocyte-containing gels displayed lower 
indentation moduli [166-189 Pa vs. 278-291 Pa, measured on days 1, 3, and 5 after 









/dyn/s, measured on days 2-5 after gelling, p < 
0.05 for all days except day 3, figure 4-2(B)].  Elastic moduli and hydraulic 
permeabilities did not vary significantly with time, for both cell-free and adipocyte-
containing collagen gels (p = 0.59 and 0.88 for moduli and p = 0.12 and 0.33 for 
hydraulic permeability, for cell-free and cell-laden gels, respectively).   
 
Engineered adipose tissues possess functional vasculature and remain viable 
Endothelial cells that were seeded in a channel within an adipocyte-containing gel 
reached confluence within one day of perfusion.  The channel diameter expanded from 
120 µm to ~190 µm over 3-3 days, and stabilized at this larger size (figure 4-3(A)).  The 
flow rate was initially ~0.5 mL/hr and increased to 1.6 ± 0.3 mL/hr after the channel 
widened. 
Staining for the endothelial cell junctional protein CD31 showed that the  
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FIGURE 4-2.  Mechanical properties of adipocyte-containing and cell-free collagen gels 












FIGURE 4-3.  Structural and basic functional characterization of vascularized adipose 
tissues.  (A) Phase-contrast image of vascularized tissue on day 3.  (B) CD31 (green) and 
Nile Red (red) stain of endothelium and 3T3-L1 adipocytes, respectively.  Inset: cross-
sectional view.  (C) Live cell (green), dead cell (red), and nuclei (blue) stain of adipose 
tissue on day 3.  (D) Fluorescence images taken after twenty minutes of vascular 
perfusion with Alexa Fluor 594-conjugated BSA.  (E) Vascular permeability coefficients 
to BSA (PBSA).  (F) Vascular permeability coefficients to 10 kDa dextran (Pdex).  **, p 












engineered tissue possessed confluent endothelium after one day of perfusion (figure 3- 
3(B)).  We observed that the diameter of the vessels that were formed in adipocyte- 
containing gels varied across the lengths of the vessels.  This result is in contrast to 
vessels that were formed in adipocyte-free collagen gel, which possessed smoothly 
tapering lumens across their lengths 
55, 57
.  The presence of adipocytes was confirmed by 
staining for neutral lipid with Nile Red (figure 4-3(B)).  To prove that the adipocytes 
were viable, we stained the tissue with calcein AM and ethidium homodimer (figure 4-
3(C)).  We found a viability rate of >99% (n = 3) for endothelial cells and 93 ± 3% (n = 
5) for adipocytes after three days of perfusion.   
To characterize the barrier function of the vessels, we carried out permeability 
assays on vessels in adipocyte-free collagen gels and in adipocyte-containing collagen 
gels that were perfused under standard conditions, and in adipocyte-containing collagen 
gels that were perfused with media that was supplemented with 10 µg/mL insulin and 0.5 
mg/mL Intralipid starting from day 1 of perfusion (figure 4-3 (D-F)).  Permeability 
coefficients for BSA for these three conditions were: (9.0 ± 3.4) × 10
-7
 cm/s, (2.7 ± 1.0) × 
10
-6
 cm/s, and (2.6 ± 1.0) × 10
-6
 cm/s, respectively (figure 4-3(E)).  Vessels that were 
formed in adipocyte-containing gels exhibited a three-fold increase in permeability to 
BSA compared to vessels in adipocyte-free gels, regardless of the presence of insulin and 
Intralipid (p < 0.001 for adipocyte-free vs. adipocyte-containing without supplements, p 
< 0.01 for adipocyte-free vs. adipocyte-containing with supplements).  Perfusion with 
insulin and Intralipid did not change vessel permeability in adipocyte-containing gels (p = 
0.81, figure 4-3(E)).  Permeabilities to 10 kDa dextran were (1.3 ± 0.4) × 10
-6
 cm/s, (4.8 
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± 1.9) × 10
-6
 cm/s, and (5.1 ± 1.3) × 10
-6
 cm/s for the three conditions, respectively; 
again, the addition of adipocytes led to higher permeability (p < 0.01), while insulin and 
Intralipid had no effect (p = 0.97, figure 4-3(F)).   
 
Adipose tissues respond appropriately to lipogenic and lipolytic hormones 
To examine the lipogenic response of vascularized adipose tissues, we switched 
some tissues to perfusion with media that contained insulin and Intralipid, starting on day 
1.  After four more days of perfusion, adipose tissues that were treated with insulin and 
Intralipid had clearly larger lipid droplets (figure 4-4(A)).  The tissues showed a 72 ± 
18% increase in lipid droplet area per cell over four days, which is higher than the 24 ± 
22% increase in tissues that were perfused without lipogenic supplements (p < 0.001, 
figure 4-4(B)).   
To examine the lipolytic response, we switched tissues that were previously 
perfused with insulin- and Intralipid-supplemented media to perfusion media with or 
without epinephrine, starting on day 5.  After an additional four days of perfusion, tissues 
that were treated with epinephrine had shrunken lipid droplets (figure 4-4(C)); in 
contrast, tissues that were not perfused with epinephrine maintained their lipid droplets.  
Tissues that were perfused with epinephrine-supplemented media showed marked 
decrease (-33 ± 3%) in lipid droplet area per cell over four days (p < 0.001, compared to 
tissues perfused with media without epinephrine, figure 4-4(D)).  Eventually, the lipid 
droplets in epinephrine-treated tissues regressed to a size similar to those on day 1 of 
perfusion, i.e., before lipogenic or lipolytic supplements were added. 
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FIGURE 4-4.  Response of adipose tissues to vascular perfusion with lipoactive 
hormones.  (A) Phase-contrast images of adipocytes before (left) and after (right) four 
days of perfusion with media that was supplemented with insulin and Intralipid.  (B) 
Lipid droplet area per cell in response to perfusion with insulin and Intralipid.  Plotted 
values are normalized to the value on day 1 (i.e., when insulin was first added).  (C) 
Phase-contrast images of adipocytes before (left) and after (right) four days of perfusion 
with media that was supplemented with epinephrine.  (D) Lipid droplet area per cell in 
response to perfusion with epinephrine.  Plotted values are normalized to the value on 









Vascular perfusion supports a gradient of adipocyte lipogenesis in centimeter-scale 
tissues 
To better understand the separation between adipocytes and the vessel affects 
adipocyte function, we formed tissues that extended up to 10 mm away from the vessel 
wall with two adipocyte densities.  In these tissues, after seven days of perfusion (the last 
six days with insulin and Intralipid), adipocytes that were near the microvessel appeared 
visibly larger compared to those that were further away from the vessel (figure 4-5(A)).  
In tissues that contained 10
6
 cells/mL, adipocytes that were within 1 mm from the vessel 
showed a 115 ± 21% increase in lipid droplet area over six days, whereas adipocytes that 
were further than 9 mm away showed modest growth (21 ± 13%, figure 4-5(B)).  In 
tissues that contained 1.5 × 10
6
 cells/mL, adipocytes that were within 1 mm from the 
vessel showed a 105 ± 23% increase over six days, whereas adipocytes that were further 
than 9 mm away showed essentially no growth (figure 4-5(C)).  For both cell 
concentrations, most of the lipid accumulation occurred between days 1 and 5, with only 
little further growth from day 5 to day 7. 
 
Discussion 
In this study, we engineered small-scale adipose tissues that contained perfusable 
microvessels.  The tissues were formed by micromolding suspensions of differentiated 
3T3-L1 adipocytes in type I collagen around an empty channel that subsequently served 
as a template for endothelialization.  We found that adipocyte-laden collagen had ~40% 
lower stiffness and ~50% higher hydraulic permeability, compared to bare collagen gel.   
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FIGURE 4-5.  Growth of adipocytes at different distances from the vessel wall.  (A) 
Representative phase-contrast images of adipocytes at 0-1 and 9-10 mm from the vessel 
after six days of perfusion with media that contained insulin and Intralipid.  (B) Lipid 
droplet area per cell for adipocytes at different distances from the vessel in tissues with 
106 adipocytes/mL.  (C) Lipid droplet area per cell for adipocytes at different distances 
from the vessel in tissues with 1.5 × 106 adipocytes/mL.  (D) Measured and computed 
(fitted) adipocyte growth at day 7 in tissues with 106 adipocytes/mL.  (E) Measured and 










Although adding adipocytes to collagen reduced the collagen concentration, the 
change was small (~3%), and it is unlikely that the observed differences in physical 
properties can be explained primarily by the dependence of stiffness and hydraulic 
permeability on gel concentration.  Remodeling of collagen by embedded adipocytes may 
contribute to the physical changes.  Accumulation of lipid over a span of up to five days 
in culture did not appear to alter the mechanical properties of the formed tissues. 
The flow rates and vessel diameters in the current study were larger than those 
measured for vessels in adipocyte-free gels from previous work 
55
, most likely because 
the adipocyte-containing gels were less stiff.  Adding adipocytes to the collagen gel also 
resulted in a three-fold increase in vascular permeability to both BSA and 10 kDa 
dextran.  This result can potentially be explained from the disruption of endothelial 
barrier function by free fatty acids 
82
 and by adipocyte-secreted permeability factors, such 
as vascular endothelial growth factor 
83
.  The unevenness of the vascular profiles that we 
observed only in adipocyte-containing tissues may also have a permeability-enhancing 
effect.  Differences in vascular shear stress, which can alter solute permeability 
57
, are 
unlikely to be responsible here; from the measured flow rates, we estimated the average 
vascular shear stress to be ~12 dyn/cm
2
 in adipocyte-containing samples and ~13 
dyn/cm
2
 in adipocyte-free samples.   
Insulin increases lipid accumulation in adipocytes through multiple pathways, 
including enhancing the conversion of circulating triacylglycerol to fatty acid 
74
 and 
increasing the uptake of free fatty acid by adipocytes 
73
.  Conversely, epinephrine 
accelerates the breakdown of stored triglyceride into free fatty acids during periods of 
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high energy demand such as fasting or exercise 
84
.  Both hormones are important 
mediators of metabolic conditions such as obesity and diabetes.  It is therefore important 
to show that engineered adipose tissue can respond appropriately to lipoactive hormones 
with lipogenesis or lipolysis.  While many previous studies used either total lipid content 
79, 85
 or lipid droplet diameter 
86
 as a measure of lipid accumulation, neither method is 
suitable for the current study.  The first method requires lysing the cells to release stored 
triglyceride, which prevents tracking adipocyte growth over time in the same sample.  
The second method is best-suited for unilocular adipocytes such as mature human white 
adipocytes and not for multilocular 3T3-L1 cells.  We therefore measured change in lipid 
droplet area per cell as a surrogate for lipogenesis and lipolysis. 
We observed ~70% increase in lipid droplet area per cell in adipose tissue after four days 
of perfusion with insulin and Intralipid, whereas adipose tissue perfused without insulin 
and Intralipid only showed a ~25% increase.  While the effects of insulin and Intralipid 
were not studied separately, our findings indicate that the engineered adipose tissues 
responded to lipogenic compounds with increased lipid accumulation.  Similarly, adipose 
tissues that were previously “fattened” with insulin and Intralipid showed ~30% decrease 
in lipid droplet area per cell upon removal of insulin/Intralipid and addition of 
epinephrine for four days, which is consistent with the lipolytic action of epinephrine.  
When switched to media that did not contain lipogenic or lipolytic compounds, 
adipocytes that were prefed with insulin and Intralipid neither shrunk nor showed further 
growth.   
In wide adipose tissues that were fed by a single microvessel, adipocytes that were 
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within 0-1 mm from the vessel showed roughly two-fold growth over six days in tissues 
at both high (1.5 × 10
6
 cells/mL) and low (10
6
 cells/mL) cell densities.  The lipid 
accumulation was less for adipocytes that were further away from the vessel; for 
adipocytes that were the furthest (9-10 mm) from the vessel, little accumulation of lipid 
was observed.  In low-density tissues, adipocytes that were 9-10 mm away from the 
vessels showed ~20% growth.  In high-density tissues, virtually no growth was observed 
in adipocytes that were 9-10 mm away from the vessel.  Most of the lipid accumulation 
occurred in the first four days of perfusion with lipogenic supplements. 
The plots of lipid accumulation versus distance suggest that a simple Krogh-type 
model may be used to rationalize these results.  In this model, we assume that the 
vascular delivery of a lipogenic compound was the rate-limiting factor in lipid 
accumulation, and that lipid droplet accumulation was metabolized with first-order 
kinetics.  The underlying equations for lipid accumulation are:  
                                                                                          (equation 3) 
                                                                                          (equation 4)            
where C is the concentration of lipogenic factors (insulin, Intralipid, etc.) in the 
extracellular space, x is the distance away from the vessel, ρ is the density of adipocytes 
in the tissue, kup is the uptake rate of lipogenic factors by adipocytes, G is the 
accumulation of lipid, kprod is the rate at which adipocytes accumulate lipid in response to 
the lipogenic signal, and B is the rate at which adipocytes metabolize accumulated lipid.  
This model predicts that the steady-state lipid accumulation decreases exponentially with 





















                                                                                      (equation 5) 
An exponential fit to the day 7 lipid accumulation in tissues with 10
6




 = 0.23/mm, with a goodness-of-fit R
2
 = 0.73 (figure 5(D)).  We then used 
equation 5 to predict the lipid accumulation profile of tissues with 1.5 × 10
6
 3T3-L1 
cells/mL by using the fitted coefficients and multiplying ρ by 1.5.  The resulting curve 
yielded R
2
 = 0.67 (figure 5(E)).  The reasonable agreement between experimental data 
and this model provides a quantitative tool to predict the lipid accumulation profile in 
adipose tissues that contain more complex vascular geometries. 
We have described a method for engineering lipoactive adipose tissue with pre-
patterned vasculature that allows immediate perfusion.  Our design can accommodate 
both vascular and non-vascular cell types, and we believe it can serve as a building block 
for constructing larger tissues for potential future application in soft-tissue repair.  The 
current tissue can be used as a “fat-on-a-chip” microphysiological system to model 
vessel-adipocyte interactions.  It can also be incorporated as one element of more 
complex adipose-rich tissues, such as in models of breast tumors 
58
.  To scale up the 
current tissue into a clinically implantable flap, we will need to modify these tissues so 
that they use primary human adipocytes or adipose-derived stem cells, a branching 
vascular network that can support large tissues, and a robust vascular pedicle that can 















Currently the two main methods to treat soft tissue injury: lipoinjection and 
adipocutaneous flap transfer each has its limitation.  Lipoinjection is plagued by low 
volume retention due to lack of perfusable vasculature.  Adipocutaneous flap transfer is 
limited by donor site availability.  Engineered adipose tissue with preformed, perfusable 
vasculature can potentially address these limitations and serve as an alternative method to 
treat soft tissue injury.   
In this work, we’ve identified three design criteria for engineering vascularized 
adipose tissue: 1) contains vasculature that allows immediate perfusion upon implantation,  
2) possess mechanical and physiological properties that are comparable to human adipose 
tissue, and 3) be of sufficient volume to be clinically relevant.  Based on these criteria, 
we’ve engineered two components of a vascularized, microsurgically implantable adipose 
tissue: a microscale vascularized adipose tissue that responds to perfusion of lipoactive 
hormones and an endothelialized dense collagen tube of 1 mm outer diameter that can be 
implanted into rat femoral circulation.  The first component can be used as a base unit for 
constructing larger scale adipose tissue, the second component can serve as a vascular 






Microscale, vascularized adipose tissue 
We’ve engineered a 1 mm × 1 mm × 7 mm adipose tissue containing one 
microvessel of ~190 µm diameter that enables immediate perfusion and delivery of 
nutrient to adipocytes.  We were able to achieve >90% viability rate in adipocytes in our 
tissue.  We’ve shown that microvessels formed in adipocyte-containing collagen possess 
higher permeability coefficient compared to vessels formed in collagen that does not 
contain any cells.  This is most likely due to release of permeability increasing factors 
such as free fatty acids, VEGF, and leptin by surrounding adipocytes.  Nevertheless, 
microvessel in our adipose tissue possesses good barrier function, with permeability 
coefficient comparable to coronary venules. The mechanical strength of our tissue is 
lower compared to that of human subcutaneous adipose tissue.  This is likely due to the 
low volume fraction (~3%) of adipocytes in the collagen gel, and can be improved by 
incorporating primary human white adipocytes at higher cell density.  We’ve also shown 
that adipocytes in engineered tissue respond to perfusion with lipogenic and lipolytic 
hormones, insulin and epinephrine, with increased/decreased lipid droplet sizes, 
respectively.  Furthermore, we’ve developed an analytical model that predicts lipid 
accumulation in adipocytes at varying distance from the feeding microvessel.  This model 
provides a quantitative tool that can help determining the optimal vascular geometries in 
larger scale tissue.   
While this small scale adipose tissue was intended to be a base unit for building a 
larger scale, implantable tissue, it can also be used as “organ-on-a-chip” to study 
adipocyte physiology, or pathological conditions such as obesity or breast tumor. 
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Endothelialized, dense collagen tube 
We’ve developed a method to engineer an endothelialized dense collagen tube with 
outer diameter of ≤ 1 mm.  We increased mechanical strength of collagen gel by drying, 
which increases collagen density, and then crosslinking with genipin.  Dried and 
crosslinked collagen tubes possess ultimate strength, burst pressure and compliance 
comparable to that of mammalian arteries and veins.  We’ve also demonstrated that it can 
be implanted as interpositional vascular graft in the rat femoral circulation with suture 
anastomosis and can withstand arterial perfusion.   
We’ve shown that endothelial cells of both human and rat origin were able to reach 
confluence in the lumen of collagen tubes.  However crosslinking and culture condition 
has significant effect on the endothelial stability.  Endothelium formed in tubes 
crosslinked with lower genipin concentration and cultured for longer period of time are 
more stable and resistant to surgical handling, which in turn increases the patency rate 
upon implantation.  One possible explanation is that tubes crosslinked with lower genipin 
concentration possess compliance better matching that of the endothelium.  It is also 
possible that with longer culture time, endothelial cells secrets basement membrane 
which helps stabilize the endothelium. 
While the long term patency of 40% obviously remains to be improved, we’ve 
shown that it is possible for vascular grafts of this size scale to conduct blood flow and 
remain patent without additional anti-coagulant treatment.  In addition to serving as the 
vascular pedicle to bridge engineered adipose tissue and host circulation, the dense 
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collagen tube can be also used to extend the vascular pedicles of autologous flaps should 





As mentioned, these two constructs are intended to serve as base unit for building 
larger, implantable adipose tissue.  In order to scale up the current tissue to a clinically 
implantable flap, it will be necessary to: 1) further improve the stability of endothelium in 
the dense collagen tube.  This can potentially be achieved by reducing the wall thickness 
of the collagen tube (while still maintaining sufficient strength) to further increase 
compliance, coating the tube lumen with collagen type IV for stronger endothelial cell 
adherence, and culturing seeded tubes under flow conditions.  2) Modify both the 
vascular pedicle and adipose tissue to use primary human endothelial cells and adipocytes.  
In particular, further work is required to study the behavior of human white adipocytes 
(readily available from lipoaspirate) in the engineered tissue.  3) Incorporate a branching 
vascular network in the adipose tissue to support a larger volume.  While the particular 
method to engineer the vascular network is beyond the scope of the current work, the 
adipocyte growth model we developed will be helpful in optimizing the geometrical 
design of the network.  4) Connect the dense collagen tube and the vascularized adipose 
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The permeability of blood vessels to solutes plays an important role in the 
physiology of healthy tissues.
89
  Because it is often elevated when a tissue is injured, 
vascular permeability has been used as an indicator of potential tissue dysfunction.
90, 91
  
For instance, the focal elevated permeability that often occurs in stroke patients has been 
used to predict the likelihood of hemorrhagic transformation.
92-95
  Permeability maps 
have also been used to assess the stage of a tumor.
96-98
  Qualitative tests of permeability 
that are based on the visual accumulation of a blood-borne dye
99
 have been supplanted by 




In these quantitative techniques, a radiolabeled or fluorescently labeled solute is 
injected into a blood vessel that feeds the tissue to be analyzed.  The selected vessel can 
be an artery (as in the case of clinical imaging
101
) or a microvessel (as in animal 
experiments with exteriorized tissues
102
).  Initially, the signal that is measured from the 
tissue originates solely from solute that resides within the vessels of the tissue.  As solute 
begins to escape across vessel walls into the interstitial space, the measured signal 
increases.  The rate at which the signal increases, when normalized to the starting signal 
and vascular surface area, provides a robust measure of vascular permeability that can be 
compared across different tissues, individuals, and species.
103
 
Time-lapse solute imaging data are typically analyzed with the two-compartment 
Patlak model
104, 105
, which is based on the following equation: 






  (1) 
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Here, I(t) is the area-averaged (or -integrated) signal in the tissue region-of-interest 
(ROI), which includes signals from vessels within the tissue; Iv(t) is the average signal 
that originates from the vessels within the ROI; and 0 is the permeability product PS/Vb, 
where P is the solute permeability coefficient, S is the vascular surface area, and Vb is the 
blood distribution volume for the solute in the ROI.  The Patlak model assumes that the 
extravascular concentration of solute is much smaller than the intravascular 
concentration; this assumption is valid only for short times after vascular injection of 
solute and for vessels that do not have a compromised barrier.  These conditions are 
almost certainly violated during clinical imaging of injured tissues.  Other models can 
account for tissue accumulation of solute, at the cost of additional terms.
106
 
Measurement of the tissue signal I is straightforward with magnetic resonance 
imaging (MRI) or computed tomography (CT).  Given the spatial resolution of existing 
imaging techniques, however, intravascular solute cannot be distinguished from 
extravascular solute at the level of microvessels; thus, Iv is generally unknown.  In the 
experimental setting, this problem can be avoided by rapid and sustained microinjection 
of labeled solute at a defined time immediately upstream of the ROI.
102
  In this case, Iv 
equals I immediately after microinjection.  In the clinical setting, however, solute 
injection takes place at an artery that is some distance from the ROI.
107, 108
  As a result, 
clinical permeability imaging requires the separate measurement of an arterial input 
function (AIF), the solute signal within a large feeding artery, which serves as a vascular 
reference and is assumed to be proportional to Iv.  This requirement adds time and 




Even when the AIF can be measured precisely, it is not an exact representation of 
the intravascular signal Iv.  Typical transit times from the site at which AIF is measured to 
the ROI are on the order of seconds.  As a result, the AIF is delayed and undergoes 
dispersion during transit to the ROI.  That is, Iv is a convolution of the AIF and the 
unknown solute transport characteristics of the vessels that link the AIF measurement site 
and the ROI.  If not corrected for, solute delay and dispersion can lead to large errors in 
estimated permeabilities when a simple Patlak analysis is applied.
109
  Other sources of 
error, such as partial volume effects, further limit the ability of the AIF to represent Iv 
accurately.
110
  Several studies have attempted to correct for these phenomena, mainly 




Recently, we and others have attempted “blind” deconvolution of solute imaging 
data, which can yield permeability values without knowledge of the AIF.
11A-116
  Blind 
deconvolution takes advantage of known properties of a desired signal (e.g., non-
negativity) and chooses the most likely signal that displays these properties.
117
  These 
numerical techniques were originally developed for deblurring single microscope or 
telescope images, and have recently been applied to physiological data.  By not requiring 
an AIF, blind mapping methods can potentially avoid errors associated with solute delay 
and dispersion, and thus may improve the accuracy of image-guided treatment.  Our 






In the present study, we develop a new computational method that yields 
permeability values solely from the time-lapse signal from an ROI.  This method builds 
upon past work by allowing the possibility of solute accumulation within the tissue and 
eventual return into the blood, a situation that is clinically relevant.  We validate the 
method with finite-element models of vascular solute transport, and show that it can be 
used to determine vascular permeability accurately within a reasonable computational 
time.  Finally, we compare the accuracy of the method with those of previously published 





Compartmental model of solute transport 
Our method uses a two-compartment model of solute transport that extends the 
Patlak approach by including the possibility of solute backflow: 




I k I I
dt dt
     (2) 
The last term in equation (2) accounts for reabsorption of solute into the vessel lumen, 
with a rate constant k0.  Together, the two constants 0 and k0 characterize the average 
permeability of the vessels in the ROI, and are the unknowns that we wish to obtain.  
Here, k0 equals PS/Ve, where Ve is the extravascular distribution volume for the solute in 
the ROI, and P and S are as defined earlier.  Thus, the permeability constants 0 and k0 







    (3) 
Equation (2) can be solved to give: 
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k t k t
vI t I t e e I t dt    (5) 
We assume that the vascular solute concentration is initially zero at time t = 0, rises to a 
maximum, then decreases smoothly back to zero at time t = T (the end of the imaging 
time). 
For a given or measured intensity function I(t) and guesses of  and k, we can 
obtain a predicted vascular signal: 




k t k t
vI t k I t e e I t dt  (6) 
This predicted vascular signal does not satisfy equation (2) unless  = 0 and k = k0.  
Instead, the predicted vascular signal satisfies a slightly different equation: 
     v v v
dIdI
I k I I
dt dt
 (7) 
Our method of determining permeability constants consists of searching for the 
values of  and k that yield a vascular signal that displays a value and slope of zero at the 
end of the time series.  As shown in the Appendix, this search—assuming it converges—
will yield the correct 0 and k0. 
 
Algorithm for estimating permeability constants 
Because I(t) is measured clinically only at a finite set of times ti, i = 1, … , N, 
equation (6) must be discretized first: 








v i i j j
j
I t k I t e c e I t  (8) 
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where the cj are coefficients chosen to implement an extended form of Simpson's Rule.  
The search algorithm starts at  = k = 0, which leads to    v i iI t I t .  In all clinically 
relevant cases, the tissue signal I(t) will be non-zero and decreasing at the end of the time 
series.  We first increase  until the predicted long-term vascular signal  vI T is zero.  
We then increase k by a small increment, and repeat the procedure to map the values of  
and k where   ; , 0vI T k .  In principle, this "staircase" search strategy should 
eventually yield the values of  and k where   ; , 0vI T k and    ; , 0vI T k t ; these 
values represent the best estimates of 0 and k0. 
 
Numerical Methods 
To test the ability of this algorithm to predict the correct vascular permeabilities, 
we used two complementary approaches.  The first approach assumed that compartmental 
analysis was exact; that is, we selected a vascular input Iv(t) to model the desired level of 
solute delay and dispersion, and used equation (4) to determine the theoretical I(t) for this 
Iv input and true permeability values 0 and k0.  The fascular signal was 
      
2 22 2 1 / /( / )( )t tvI t t e e , where  is the dispersion time and  controlled the 
degree of reaction; this function was time-shifted to simulate solute elay.  We then 
discretely sampled I(t) to provide an intensity signal that served as the input dataset for 
the algorithm.  Gaussian noise with a signal-to-noise ratio (SNR) of at least 20 was added 
to I, and the permeability algorithm was executed to yield the predicted permeability 
values  and k; this process was performed for at least three hundred noisy simulations.  
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The long-term value and slope of the predicted vascular input  ; ,vI t k were calculated 
from an averaging window that extended from t = T∆T to t = T; changing the length of 





 percentile values of  and k were obtained for each model.  We also 
noted the frequency at which the algorithm did not converge or at which it incorrectly 
predicted k to equal zero. 
The second validation approach used finite-element modeling to calculate the 
solute intensity profiles as a function of time in a capillary-containing tissue cylinder, 
effectively performing an "in silico" imaging experiment.  Here, we explicitly modeled 
the advection and diffusion of solute in tissues with different capillary diameters and 
inter-capillary spacing.  The solute input to the capillary was taken to have the same form 
as for the compartmental approach, but the assumptions that underlie compartmental 
analysis (i.e., instantaneous mixing of vascular solute, instantaneous mixing of 
extravascular solute) were not imposed.  The solute concentration was integrated over the 
tissue volume (including the capillary space) to yield I(t) at discrete times.  Gaussian 
noise was then added to I, and the resulting intensity signal was used as the input to the 
permeability algorithm.  For each finite-element model, three hundred noisy simulations 
were performed to obtain media, 5
th
 percentile, and 95
th
 percentile values of predicted  
and k.  All finite-element models were solved with COMSOL Multiphysics ver. 3.5a 
(Comsol, Inc.), and models were meshed iteratively until two sequential meshes yielded 
I(t) curves that differed by <0.01%. 
In some cases, Patlak analysis was performed for comparison.
30
  Here, the arterial 
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input unction (SIF) was assumed to have the same form as Iv  with =6.7 s and no 
recirculation, and a linear fit of I(t)/AIF(t) versus 0 ( ) / ( )
t




Figure A-1 illustrates the basic ideas that underlie the permeability algorithm, for a 
simple bolus vascular input of finite width with true permeability constants 0 = 0.05/s 
and k0 = 0.0025/s.  The bolus was modeled by with  = 10 sm no delay, and no 
recirculaiton (Fig. A-1A).  This vascular input resulted in a tissue intensity I(t) that rose 
simultaneously with the input, but did not decrease back to zero by the end of the 
sampling period (Fig. A-1B).  Sampling I(t) once per second over a total time of T = 60 s 
yielded a noise-free time series (Fig. 1C) that we used to test the accuracy of the 
algorithm without the confounding effects of noise. 
Using equation (8) with  = 0 and k = k0 yielded a predicted vascular input that 
nearly matched the theoretical input Iv (Fig. A-1D, center).  Deviating from these ideal 
values led to characteristic changes in the shape of the predicted input function
vI .  In 
general, increasing  while holding k constant caused a decrease in the predicted vascular 
input, so that  ; ,vI t k became negative at long times for  > 0.  Increasing k while 
holding  constant led to an increase in the predicted vascular input, but with a smaller 
change.  As the curves in Fig. A-1D show, only when  ≈ 0 and k ≈ k0 did the predicted 
signal exhibit both of the characteristics of the theoretical input, namely, that the long- 
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FIGURE A-1.  Representative example of the permeability algorithm.  (A) Vascular 
signal for a bolus injection, modeled by      
2 22 2 1 t
vI t t e with  = 10 s.  (B) 
Corresponding tissue signal I(t) for true permeability constants 0 = 0.05/s and k0 = 
0.0025/s, found by solving equation (2).  (C) Discretely sampled I(ti) with a sampling 
frequency of 1 Hz.  (D) Predicted vascular signal  ; ,v iI t k , for various values of  and 
k.  The predicted vI has a long-term value and slope of zero when  = 0.05/s and k = 
0.0025/s.  Calculation of the long-term value and slope of  ; ,vI t k used the last two 











term value and slope of the vascular input curve were both zero.  An iterative search with 
a resolution of 5×10
−5
/s yielded  = 0.05/s and k = 0.0025/s as the values for which the 
long-term vascular input and slope were exactly zero; thus, the error that resulted from 
discretization at the sampling frequency of 1 Hz was negligible for this case. 
 
Optimization of imaging parameters 
To determine the optimal imaging conditions that would yield the most accurate 
permeability predictions, we varied the total imaging time T, the size of the averaging 
time window T, and the signal-to-noise ratio SNR.  These simulations were performed 
with the same bolus vascular input described above, with  = 10 s; the theoretical 
permeability values remained 0 = 0.05/s and k0 = 0.0025/s.  In preliminary work, we 
found that more frequent time sampling always led to more accurate permeabilities; thus, 
we selected the highest sampling frequency (1 Hz) that was consistent with typical 
clinical imaging.  For the other parameters, we first varied T, then ∆T, and finally SNR to 
determine the main factors that control the accuracy of the permeability algorithm for this 
particular vascular input.  . 
Varying the total imaging time T revealed that the longer the imaging time, the more 
accurate the permeability values, but only in the absence of signal noise (Fig. A-2A).  
Surprisingly, for noisy imaging data with SNR = 40, longer imaging times did not always 
yield more accurate permeability values.  The optimal imaging time that minimized the 
variability in  was T ≈ 40 s; the variability in k depended less strongly on T for long 
imaging times.  We also found that, only when applied to noisy data, the algorithm often 
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FIGURE A-2.  Errors in the predicted permeability constants  and k, and frequency of 
algorithm error, as functions of (A) total imaging time T, (B) length of averaging time 
window ∆T, and (C) signal-to-noise ratio SNR.  The "base case" model for these 















did not converge or yielded k = 0 when the imaging time was greater than ~40 s.  This 
result suggests that the increased variability when predicting permeabilities from long, 
noisy imaging originated from the effects of noise on the determination of the long-term 
value and slope of the vascular. 
One potential strategy for mitigating the effects of noise is to change the length of  
the averaging time window that is used to obtain the long-term vascular input and slope.  
In principle, increasing the time window could improve the accuracy of the algorithm, 
because more time-points would be averaged.  On the other hand, if the averaging 
window was extended to include times before the vascular input decayed to zero, then the 
accuracy of the algorithm could worsen.  Indeed, we found that the predicted 
permeabilities were noticeably more inaccurate for both short (T < 10 s) and long (T > 
16 s) averaging windows (Fig. A-2B).  For short averaging windows, the variability in 
predicted permeability was large only in the presence of noise.  For long averaging 
windows, the variability was small, but a systematic overestimation of both  and k 
emerged.  When the averaging window was shorter than ~10 s, both types of algorithm 
errors (lack of convergence, k = 0) became much more frequent.  For an averaging 
window of 3 s, the total error rate was nearly 50% with noise. 
Finally, we determined how the accuracy of the algorithm depended on signal-to-
noise ratio SNR (Fig. A-2C).  As expected, higher SNR led to more accurate predictions.  
For SNR below ~30, the algorithm became very inaccurate, with large error rates.  At a 




Optimized accuracy of the permeability algorithm 
The above results suggest that the potential improvement in algorithm accuracy 
with long imaging times can only be realized with long averaging windows.  Thus, we 
selected optimized imaging conditions of T = 60 s and averaging window of thirty time-
points (i.e., T = 29 s); the imaging frequency and signal-to-noise ratio were kept at 1 Hz 
and 40, respectively.  With these conditions, we performed a parametric sweep to 
determine the accuracy of the permeability algorithm across a wide range of true 
permeability values 0 (Fig. A-3A) and k0 (Fig. A-3B).  In general, the errors in  tended 
to be substantially smaller than those in k.  Across the ranges of values examined,  was 
predicted to within ~10% error, while the error in k depended on the true permeability 
values.  For small 0 or k0, the algorithm predicted k poorly, with errors on the order of 
100% for smallest 0 and k0 examined. 
We also determined the accuracy of the algorithm when the vascular input did not 
decay to zero by the end of the imaging time (Fig. A-3C).  These simulations were 
intended to model the presence of solute recirculation.  By holding  = 10 s while varying 
 between 0 and 0.5, we controlled the residual level of vascular input between 0% and 2% 
of the maximum vascular input intensity.  Residual vascular input of up to ~1% resulted 
in average systematic errors in  of up to 30%.  Surprisingly, the algorithm gave more 






FIGURE A-3.  Errors in the predicted permeability constants  and k, as functions of 
true permeability values (A) 0 and (B) k0, and (C) the residual vascular signal.  Ilast and 
Imax refer to the theoretical value of I(T) and maximum of I(t), respectively.  The "base 
case" model for these simulations had 0 = 0.05/s, k0 = 0.0025/s, T = 60 s, ∆T = 29 s, and 











Validation with spatially and temporally resolved solute transport models 
The above analysis assumes that a two-compartment model can describe 
microvascular solute transport exactly.  Both assumptions of the compartmental model, 
namely, that the intra- and extravascular gradients in solute concentration are negligible, 
hold only when the vascular flow rate is large and the tissue space is small.  When the 
vascular flow speed is limiting and/or when the inter-vessel spacing is large, these 
gradients may be substantial.  Thus, we performed a more stringent test of the 
permeability algorithm by using computed imaging data that were extracted from finite- 
element models of solute transport.  These models did not assume the existence of well-
mixed compartments and served as "in silico" imaging experiments. 
In these simulations, we modeled the transport of solute within a capillary-
containing tissue cylinder.  The vascular input consisted of a delayed and dispersed 
signal.  The solute concentration within the tissue cylinder, including that in the capillary 
space, was integrated to yield the amount of solute as a function of time.  This integrated 
signal was analogous to an intensity signal in a single voxel from clinical imaging, and 
was used as the input to the permeability algorithm. 
As before, we assumed that the total imaging time was 60 s and used the last 30 s as the 
averaging window; we also assumed a signal-to-noise ratio of 40.  We varied the solute 
permeability coefficient P and the inter-capillary spacing 2rt (Fig. A-4A), and the solute 
input delay and dispersion times  To aid in visualization, we used the algorithm to "map" 
the permeability in a rectangular array, in which each voxel corresponded to different 
combinations of permeability constants, capillary geometries, and/or solute  
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FIGURE A-4.  Arrays of predicted permeability coefficients using imaging data that 
were generated from finite-element models of solute transport in a capillary-containing 
tissue cylinder. (A) Predicted with a bolus vascular input of   = 10 s, no delay, and no 
recirculation. (B) Predicted with true permeability P = 1.25×10
−5
 cm/s and intercapillary 
spacing 2rt = 45 µm. (C, D) Predicted k using the same models as in (A) and (B), 
respectively. Left, true permeabilities. Center, permeabilities that were calculated from 











input times.  The true permeability constants were calculated as 0 = 2P/r0 and
 2 20 0 02 tk Pr r r  , where r0 is the capillary radius (taken to be 5 m).  For 
comparison, we created analogous maps from traditional Patlak analysis
118
, which 
assumes fast vascular mixing and negligible extravascular accumulation of solute. 
These permeability maps showed that our algorithm predicted the permeability 
constants α0 and k0 accurately across a broad range of permeabilities and capillary 
spacings (Fig. A-4). In contrast, the Patlak analysis overestimated large permeabilities 
and underestimated small ones, and often failed to yield a positive value in the presence 
of delay and dispersion (Fig. A-4A, 4B).Finally, we tested the ability of the optimized 
algorithm to map permeability in a model tissue (Fig. A-5).  This tissue was designed to 
mimic the presence of a tumor with elevated vascular permeability and vascular space, 
with randomly different capillary geometries.  Again we found that current algorithm 
outperformed Patlak analysis, and provided a much sharper outline and more accurate 
values for high-permeability region. 
 
DISCUSSION 
The algorithm that this study developed successfully predicted vascular 
permeability across a broad range of permeabilities, vascular geometries, and vascular 
inputs, all without knowledge of an arterial input function (AIF).  Although the AIF can 
be measured in clinical imaging by selectively analyzing the signal intensity within a 
feeding artery, the AIF is measured upstream from the actual vascular input to a given 
tissue voxel.  Our algorithm improves upon the state-of-the-art methods for measuring  
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FIGURE A-5.  Permeability mapping of a model tissue in which a central region of high 
permeability (P = 2.5×10
−5
 cm/s) is surrounded by regions of baseline permeability (P = 
1.9×10
−5
 cm/s). Vascular input had a dispersion time of 10 s and no delay or 


















vascular permeability by not requiring calculation of the AIF. 
At first, it may seem implausible that enough information could be obtained from 
time-lapse imaging data I(t) to obtain permeability values.  After all, I(t) is a convolution 
of the unknown vascular input Iv(t) and the unknown vascular permeabilities 0 and k0.  
This type of "blind" deconvolution has been performed successfully in other fields, by 
relying on prior knowledge of certain qualities of the input signal.  In the current study, 
these requirements consisted of: 1) Iv(t) decays to zero by the end of the imaging time, 2) 
Iv(t) reaches a slope of zero by the end of the imaging time, and 3) Iv(t) is non-negative.  
In practice, the last requirement was unnecessary, and enforcing the first two conditions 
was sufficient to obtain unique predicted permeability constants  and k. 
Compared with the current state-of-the-art (i.e., Patlak analysis), the algorithm  
described here performed very well.  By design, it is immune to solute delay, and it is 
also largely unaffected by solute dispersion.  In contrast, Patlak analysis often yields 
erroneous values when the solute is delayed, and subjective adjustments of the imaging 
data are required.  The current algorithm also improved upon the blind approach that we 
developed previously
116
, which did not account for solute return to the vascular space. 
The algorithm was fast, typically requiring only a few seconds to complete the 
permeability calculations.  For a typical clinical image slice resolution of 128128 pixels, 
it should be possible to use parallel computing to generate a permeability map within 





Sources of error 
We have identified several sources of error in the permeability algorithm, and 
found ways to minimize them.  The main error results from signal noise.  For SNR of 30 
or less, the algorithm often did not converge, or yielded an erroneous prediction of k = 0.  
Even when the algorithm converged, the errors in  and k were often quite large.  To 
some extent, these errors could be decreased by enlarging the averaging window T.  Our 
results showed, however, that increasing T gave limited improvement, since eventually 
T became so large that the average true long-term vascular input and slope were no 
longer zero.  A simpler solution to the issue of noisy data is to bin the imaging signal 
across neighboring voxels (similar to a spatial averaging filter).  Regardless of the exact 
strategy used, our data indicate that SNR of at least 40 is needed for good performance of 
the permeability algorithm. 
A second source of error stemmed from the long-term behavior of the vascular 
input.  Our algorithm assumes that the vascular signal decays to zero by the end of the 
imaging time.  In practice, injected solute is never completely cleared from the 
bloodstream during imaging, and the residual signal is typically on the order of 1% of the 
maximum.  Our results suggest that keeping the residual vascular signal at most 1% of 
the maximum will lead to less than ~30% error in .  This level of residual solute should 
be achievable with clinical imaging times on the order of minutes. 
The remaining sources of error—discretization of the continuous intensity I(t), and 
compartmentalization of the vascular and extravascular spaces—were less important.  
Errors due to discretization were modest (typically <10)  To assess errors due to 
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compartmentalization, we used finite-element models to simulate an actual imaging 
experiment.  As shown in Figures A-4 and A-5, the predicted permeability values 




The algorithm described in this study enables one to map vascular permeabilities 
from time-lapse imaging data without knowledge of an arterial input function. Our results 
indicate that the errors associated with this "blind" deconvolution of imaging data can be 
surprisingly small under clinically acceptable imaging settings (signal-to-noise ratio of 
40, total imaging time of 60 s, and imaging frequency of 1 Hz). Perhaps most 
importantly, this algorithm performs well in the presence of solute delay and dispersion. 
Incorporation of this algorithm into current commercially available programs for vascular 
imaging should be straightforward, and should increase the accuracy of permeability 
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